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ABSTRACT
Structures of Poliovirus and Antibody Complexes
Reveal Movements of the Capsid Protein VP1 During Cell Entry
Jun Lin
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
In the infection process, native poliovirus (160S) first converts to a cell-entry
intermediate (135S) particle, which causes the externalization of capsid proteins VP4 and the Nterminus of VP1 (residues 1-53). The externalization of these entities is followed by release of
the RNA genome, leaving an empty (80S) particle. Three antibodies were utilized to track the
location of VP1 residues in different states of poliovirus by cryogenic electron microscopy (cryoEM).
“P1” antibody binds to N-terminal residues 24-40 of VP1. Three-dimensional
reconstruction of 135S-P1 showed that P1 binds to a prominent capsid peak known as the
“propeller tip”. In contrast, our initial 80S-P1 reconstruction showed P1 Fabs also binding to a
second site, ~60 Å distant, at the icosahedral twofold axes. Analysis of 80S-P1 reconstructions
showed that the overall population of 80S-P1 particles consisted of three kinds of capsids: those
with P1 Fabs bound only at the propeller tips; only at the twofold axes; or simultaneously at both
positions. Our results indicate that, in 80S particles, a significant fraction of VP1 can deviate
from icosahedral symmetry. Similar deviations from icosahedral symmetry may be biologically
significant during other viral transitions.
“C3” antibody binds to 93-103 residues (BC loop) of VP1. The C3 epitope shifts
outwards in radius by 4.5% and twists through 15° in the 160S-to-135S transition, but appears
unchanged in the 135S-to-80S transition. In addition, binding of C3 to either 160S or 135S
particles causes residues of the BC loop to move an estimated 5 (±2) Å, indicating flexibility.
The flexibility of BC loop may play a role in cell-entry interactions.
At 37 °C, the structure of poliovirus is dynamic, and internal polypeptides VP4 and the
N-terminus of VP1 externalize reversibly. An antibody, binding to the residues 39-55 of VP1,
was utilized to track the location of the N-terminus of VP1 in 160S particle in the “breathing”
state. The resulting reconstruction showed the capsid expands similarly to the irreversibly altered
135S particle, but the N-terminus of VP1 is located near the twofold axes, instead of the
propeller tip as in 135S particles.

Keywords: cryo-electron microscopy, picornavirus, three-dimensional image reconstruction,
viral cell entry, viral uncoating
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Chapter 1. Introduction

1.1 Cell Entry of Non-Enveloped Viruses
For animal viruses to effectively initiate infection into a host cell, they must bind to an
appropriate cell-surface receptor and then deliver their nucleic acid to the appropriate cellular
compartment. Enveloped viruses such as human immunodeficiency virus (HIV) and influenza
virus deliver their genome by fusing the viral membrane with the host cell membrane at the cell
surface or within endocytic vesicles. Non-enveloped viruses must provide another mechanism to
allow their protein-encased genomes to enter their hosts. These mechanisms are thought to be
either endosomal lysis or pore formation (1, 2). For the most part, the cell-entry mechanisms of
non-enveloped virus are not well understood. However, cryo-EM analysis of polioviruses has
provided some detailed information on structural changes during cell entry (3-7).

1.2 Picornavirus Structure and Cell Entry
Picornaviruses are small, icosahedral, non-enveloped viruses with a single positive strand RNA
genome. The fundamental picornavirus capsid architecture is the same in all members and is
composed of 60 copies of each of four structural proteins, VP1 to VP4, arranged with
icosahedral symmetry. VP1, VP2, and VP3 form the outer surface of the capsid, having eight
stranded antiparallel β-sheet structures with a "jelly roll" topology. VP4 lies in an extended
conformation on the inner surface of the capsid (Fig. 1.1).
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Figure 1.1 The crystal structure of the poliovirus capsid proteins (8). One asymmetric unit shows ribbon
diagrams of VP1 (blue), VP2 (yellow), VP3 (red), and VP4 (green). The outer surface faces the reader.

During cell entry, picornaviruses at first attach to the cell via an interaction with specific
receptors on the cell membrane. The next step of picornavirus infection is uncoating, where the
viral capsid forms an opening to release the genome into the infected cell. Although cell entry
and uncoating remains poorly understood, the cell entry of poliovirus is understood better than
that of any other picornavirus.

1.3 Poliovirus Structure and Cell Entry
Poliovirus, the prototypic member of the picornavirus family, causes poliomyelitis. Poliovirus is
an excellent model system to study non-enveloped cell-entry mechanisms because 1) procedures
for cultivating the virus and its cellular receptor (poliovirus receptor or CD155) are well
established, 2) both the virus and receptor are well characterized and 3) the structures of
poliovirus in different states are known (3-5, 7-11). The viral surface is dominated by (i) starshaped mesas at the fivefold axes surrounded by deep canyons and (ii) three-bladed propellers at
the threefold axes separated by saddle-like depressions straddling the twofold axes (Fig. 1.2).

2

Figure 1.2 Prominent structural features on the exterior of native poliovirus (3). The mesa is formed solely by
VP1, the canyon and propeller by VP1, VP2, and VP3. The propeller tip is formed by the EF loop of VP2 and
flanking polypeptide sequences from VP1 and VP3. Each mesa is centered on a fivefold symmetry axis, each
propeller is centered on a threefold symmetry axis, and each saddle-like depression is centered on a twofold
symmetry axis.

Cell-entry of poliovirus is thought to occur via a pore opening as a result of exposure to
membrane-binding entities from the capsid (2, 4, 11, 12). The virion (sedimentation coefficient,
160S) interacts with its receptor CD155 at the canyon (Fig.1.3) (10) and changes into the cellentry intermediate (135S) form. The receptor appears to act as a catalyst (2, 13). VP4, a protein
that is known to form membrane channels in vitro (14), and the N-terminus of VP1, an entity
known to interact with lipid vesicles (12), are irreversibly externalized in the transition from
160S to 135S forms. The hypothesis is that the intermediate particle interacts with the
membrane, a channel is formed, and then RNA enters the cell (Fig. 1.4). After releasing the RNA
into the infected cell, poliovirus sediments at 80S.
Other closely related picornaviruses such as rhinoviruses, echoviruses, coxsackieviruses,
and enteroviruses are thought to use similar cell-entry mechanisms (18).
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Figure 1.3 Structure of poliovirus-CD155 complex (10). Cryo-EM reconstruction of poliovirus (red) and the
ectodomain of CD155 (cyan). Bar =100 Å.

Figure 1.4 Model of cell entry for poliovirus by Dr. David M. Belnap from references (2, 4, 15-17). This model
also is proposed for the other picornaviruses closely related to poliovirus, though cell entry in those related viruses
could occur at the cell membrane or through an endosomal membrane that has penetrated deeper into the cell.
Poliovirus virion (sedimentation coefficient = 160S) interacts with poliovirus receptor. The black dots represent the
receptor binding sites. This interaction catalyzes a conformational change to the cell-entry intermediate particle
(sedimentation coefficient = 135S). VP4 and the N-terminus of VP1, which are internal in the 160S particle, are
irreversibly externalized in the transition to 135S particle. The two externalized entities allow the 135S particle to
interact with the cell membrane. The virus particle is enclosed within a vesicle or is in a membrane invagination
that is sealed from the extracellular environment. Then, a channel forms connecting the interior of the virus and the
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cytoplasm, and the RNA is injected into the cytoplasm. The force driving RNA release is unknown. RNA release
(uncoating) occurs within approximately 200 nm of the cell membrane, so the vesicle may still be attached to the
cell membrane. The observed RNA-released particle (sedimentation coefficient = 80S) is thought to be the final
state of the virus particle after entry. 160S, 135S, 80S, and virus-receptor complexes have been structurally
characterized for poliovirus (3-5, 7-11).

1.3.1 Poliovirus “Breathing” State
“Breathing” means transient, reversible changes in protein conformation. Several nonenveloped
viruses have been shown to undergo “capsid breathing” (see Chapter 5). “Breathing” of
poliovirus was first discovered when antibodies to internal, unexposed amino-acid sequences
were found to bind to native particles (19, 20). These epitopes are part of the membrane-binding
entities irreversibly exposed during cell entry. The studies showed that “capsid breathing” might
actually represent large dynamic changes in virion structure. The “breathing” of some viruses is
easier to observe at higher temperatures. For example, “breathing” of the poliovirus capsid
occurs at 37 ºC but not at 25 ºC (19, 21) and “breathing” of the human rhinovirus 16 capsid
occurs at 25 ºC but not at 4 ºC (22). If “breathing” is important for picornavirus cell entry then
presumably it includes conformational changes necessary for receptor-binding, cell-entry, and
the eventual triggering of genomic release (uncoating) in many or all non-enveloped viruses. The
transient exposure of internal proteins may be an important step for the cell-entry process,
especially the conformational changes required to insert internal, hydrophobic, membranebinding peptides into the membrane. Antiviral agents, antibodies, or mutations, which can block
viral “breathing”, can prevent viral infection (21, 23-25). Whether the reversible changes in
“breathing” are similar to the irreversible changes that occur during cell entry is an important
question, and Chapter 5 will provide some information about this question.
5

1.3.2 Poliovirus Intermediate
The 160S particle interacts with CD155 on the host cell and changes into the intermediate 135S
particle. The formation of 135S particles of poliovirus can be induced (11) by membrane extracts
(26), solubilized receptor (27, 28), soluble ectodomains of the receptor (29, 30), or by heat
treatment (31). The 160S-to-135S transition includes the externalization of VP4 and the Nterminus of VP1. One early poliovirus entry model suggests that receptor binding induces
changes that widen the channel at the fivefold axes, allowing VP4, the N-terminus of VP1, and
the viral RNA to exit the capsid at the particle fivefold axes (Fig. 1.5 A, B) (32-34). The location
of the N-terminus of VP1 in the intermediate (135S) particle will give evidence to verify or
modify the entry model. In the 135S particles, the V8 protease of Staphylococcus aureus
specifically cleaves after a glutamate at position 31 of VP1 and a V8-proteolyzed 135S particle
cryo-EM reconstruction was obtained (4). By comparing the 135S structure with the V8proteolyzed 135S structure, Bubeck et al. found that the N-terminus of VP1 is located at the
propeller tip, near the canyon. Based on the new finding that the N-terminus of VP1 does not exit
the capsid at the fivefold axis, but near the canyon, an alternative model for poliovirus entry was
suggested (Fig.1.5 A,C,D) (4).
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Figure 1.5 Working models for poliovirus entry (A-D from (4) and E-F are adapted from Bubeck et.
al. (4) encoding the concept that RNA exits from 2-fold axis (7). A cross section of a portion of the capsid is
shown in dark blue, VP4 is green, and the N-terminus of VP1 is cyan and magenta. The V8 cleavage site is shown as
a green circle. (A) Native poliovirus binds its receptor, Pvr (ectodomains 1 to 3, tan; transmembrane domain, black
helix), and at physiological temperature undergoes an irreversible change to the 135S particle. The path of egress of
the N-terminus of VP1, suggested by the 135S reconstruction (4), would not preclude the continued binding of Pvr.
(B to F) Alternative models for the direct anchoring of the virus to the membrane via the N-terminus of VP1 and
formation of a transmembrane pore for RNA translocation. (B to D) RNA exits at a fivefold axis. The VP3 tube
(red) blocks an otherwise open channel along the fivefold axis. To accommodate the passage of RNA (purple), the
VP3 tube has shifted, and the channel has expanded, becoming continuous with a pore through the membrane. (E
and F) are adapted from (C and D) (4, 7) RNA exits near a twofold axis between 2 propeller tips. The VP3 tube at
the fivefold axis helps fix the relative position between viral proteins and helps keep the capsid rigid, In this model,
because RNA does not exit at a fivefold axis, VP3 tube does not shift, which is consist with the VP3 tube in stable in
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all states of poliovirus (2). (B) Amphipathic helices at the N-terminus of VP1 (cyan) may form a five-helix bundle
close to the fivefold axis, which would require the magenta helix to dissociate from the body of the virus.
Alternatively, VP4 may play a more central role in pore formation (C to F). In that case, VP1 may participate
directly in forming the pore (D and F) or serve as a nonspecific membrane anchor (C and E).

1.3.3 Empty Poliovirus
The empty 80S particles are thought to be the final state of poliovirus in its cell-entry process.
Recently, the Hogle lab at Harvard Medical School found that at least three states of 80S
particles exist: the early RNA-releasing form (80S.e) (6), the RNA-releasing form caught in the
act of releasing RNA (80S “caught in act”) (Fig. 1.6) (7), and the late RNA-releasing form
(80S.l) (6). The 80S “caught in act” map showed that RNA exits near the 2-fold axis toward each
neighboring 5-fold axis, and not at the 5-fold axis as has been suggested previously (7, 11).

Fig.1.6 A surface representation of two virions caught in the process of genome release (7). Icosahedral
averaging was applied only to the capsid region (green). An isocontour surface of the RNA density is rendered in
red.

Based on this new finding, that viral genome exits near the 2-fold axis, not from the 5fold axis, I modified the model for poliovirus entry, proposed by Bubeck et al. in 2005 (Fig. 1.5
C,D), and hypothesize another alternative poliovirus entry model (Fig. 1.5 E,F): Receptor
binding induces 160S to 135S conformational changes that allowing VP4 and the N-terminus of
VP1 exit at the propeller tip near the canyon (as in the previous model). The externalized VP4
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and the N-terminus of VP1 forms a channel between two propeller tips near the twofold axis, and
the viral RNA exits the capsid near the particle twofold axes.

1.4 Disease Prevention and Treatment
Structural analysis to understand the virus itself, its interactions with host cell receptors and
antibodies, and viral cell entry is important for virus disease prevention and treatment, for
example, vaccination and antiviral drugs (35, 36). Some viral diseases can be controlled and
prevented by vaccination with low cost. For picornavirus-associated diseases, vaccines have
been developed for poliomyelitis, hepatitis A, and foot-and-mouth disease (35). Synthetic
peptides from the immunogenic sequences of capsid proteins potentially could be used as
vaccines, and the antibodies induced by the synthetic peptides may block cell entry, e.g. prevent
the sequence from binding to the cellular receptor (37). Antiviral drugs could be inhibitors of
attachment, entry, uncoating, or replication (36). For picornaviruses, one of the most wellcharacterized examples are the capsid protein VP1 and viral drugs that prevent viral uncoating
(36). The WIN compounds bind poliovirus into the hydrophobic pocket, which is located
underneath the canyon floor. WIN compounds stabilize the capsid, preventing conformational
change (to the cell-entry intermediate) (36).
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Chapter 2. Cryo-Electron Microscopy Reconstruction
2.1 Biological Macromolecular Structure
X-ray crystallography, nuclear magnetic resonance (NMR) and three-dimensional electron
microscopy (3DEM) are three major methods used to solve biological macromolecular structure.
The structures determined by X-ray crystallography and NMR usually are at atomic resolution—
3DEM structures usually are not. However, X-ray crystallography and NMR have significant
limitations: A single crystal of a large biological molecule or macromolecular complex may be
very hard to grow, and the crystal form of the molecule may not be in the biologically active
state. Typically, NMR can only solve molecules less than 20 kDa in size. 3DEM, especially
images obtained by cryogenic electron microscopy (cryo-EM), can be used to determine the 3D
structures of large biological macromolecules with a molecular weight more than 200 kDa. For
one EM grid sample preparation, less than 1 pmol is sufficient.

2.2 Transmission Electron Microscopy
Transmission electron microscopy (TEM) is a microscopy technique whereby a beam of
electrons is transmitted through an ultra-thin specimen. As it passes through the specimen, the
beam interacts with the specimen. This interaction creates an image; the image is magnified and
focused onto an imaging device such as a fluorescent screen, a layer of photographic film, or a
CCD camera.
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2.3 EM Specimen Preparation Methods
2.3.1 Negative Staining
Brenner and Horne first applied the negative-staining method to observe tobacco mosaic virus
and turnip yellow mosaic virus (1). A solution of 1–2 % uranyl acetate is a typical negative
staining solution. The sample solution is placed on an electron-microscope grid coated with
evaporated carbon. After the sample is blotted with filter paper, the sample is coated by uranyl
acetate, which provides high contrast and sample protection. The negative staining method is
frequently applied to obtain high contrast images of the particle. This method is quick and
relative simple, and in my work, it was used as an important first step to obtain preliminary data
of a virus sample. Usually, before preparation of a cryo-EM specimen, a sample is checked by
negative staining to make sure that the sample itself and the solution conditions (e.g. the
concentration, pH value, buffer solution, and the ion strength) are suitable for cryo-EM sample
preparation.
Negative stain can introduce artifacts, such as “one-sidedness” and particle flattening.
Sometimes, only one side, e.g. the bottom, will be stained. As the layer of stain dries, specimens
can be flattened by surface-tension forces.

2.3.2 Cryo-EM
Cryo-EM is electron microscopy of a hydrated sample that is frozen at cryogenic temperatures
(liquid nitrogen or liquid helium temperatures). A solution of biological macromolecules is
loaded into the pores of a perforated carbon-coated grid and the molecules are embedded in
amorphous ice by rapid freezing of a sample made thin by blotting. Cryo-EM is a direct and
important method for determining the structures of large biological molecules.
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Radiation damage and the high vacuum in the EM column are two major problems that
needed to be solved to record electron micrographs of biological specimens. In 1984 at the
European Molecular Biology Laboratory, Jacques Dubochet and coworkers first introduced a
practical application of cryo-EM. They published in Nature images of adenovirus imbedded in a
vitrified layer of water (2). The problem of the high vacuum was solved by embedding the
sample in vitreous ice at cryogenic temperature (such as liquid nitrogen or liquid helium). To
diminish the effect of radiation damage, a very low dose of electrons was used to image the cryoEM sample. Since that time, the cryo-EM technique was used with 3DEM methods to produce
three-dimensional structures. These and other developments have made 3D cryo-EM a routine
technique for the structural analysis of biological molecules, especially large macromolecules.
Besides obtaining a static molecular structure, cryo-EM can be used to solve dynamic or
kinetic molecular structure. The major advantage of cryo-EM is that molecules are in their native
state (not fixed or stained). At selected time intervals, temperatures, or chemical conditions,
samples can be quickly frozen to capture macromolecular complexes in different functional
states. X-ray crystallography and NMR only provide signals from the entire sample, but for cryoEM, individual molecular images can be selected from a population and be classified into
different groups to demonstrate the structures of different conformations within the population
(such as the classification experiment in Chapter 3). A single imaged particle also can show a
particular feature (such as the one-particle reconstruction experiment in Chapter 3).

2.3.3 3D Reconstruction
In the transmission electron microscope, 3D structural information is projected into twodimensional (2D) projection images. The density at each point of a 2D projection image
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represents the summation of all densities in the sample perpendicular to this projection plane
(Fig. 2.1).

Figure 2.1 Reconstruction of a 3D structure from 2D projection images via real-space processing (3). Front,
side, and top 2D projection images (labeled as front view, side view, and top view) were acquired by projection
(gray arrows) from a model of a human left hand (labeled as 3D) with different rotations. Back-projection (white
arrows) is the opposite procedure. This reverse-projection method allows the 3-D structure to be reconstructed.

From cryo-EM micrographs, 2D projection images of each particle can be acquired.
Those 2D projections can be used to reconstruct the 3D structure via real-space processing or
Fourier transforms (3). 3D structure can be achieved by “back projection” in real (Cartesian)
space (Fig. 2.1) (3). The real-space and Fourier-transform forms of an image are interchangeable.
The Fourier transform is a representation of the image in the frequency (specifically spatial
frequency) dimension. The advantage of using Fourier transforms is filtering according to spatial
frequency. By using different filters, low-, middle- or high-spatial frequencies can be excluded to
improve a reconstruction or to aid in 3D image analysis. For example, the high spatial
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frequencies contain a much higher fraction of noise than the low or middle spatial frequencies.
These frequencies are of little use in image analysis or in computing the 3D reconstruction. The
reconstruction done by filtering high spatial frequencies shows less noise. The projection (or
central-section) theorem is the mathematical principle behind Fourier-transform reconstructions
(Fig. 2.2) (3).

Figure 2.2 The projection theorem (3). Instead of back-projecting 2D projection images to obtain the 3D structure
directly, 2D images are Fourier transformed, the Fourier transform of 2D images are the central slices of the 3D
Fourier transform normal to the viewing direction placed in the appropriate place in the 3D transform, and the
inverse Fourier transform of the 3D Fourier transform is used to convert back to real space (the 3D structure). (Note
that more unique 2D projection images provide more 3D Fourier transform information to obtain a better
reconstruction.)
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Since 1984, cryo-EM techniques and reconstruction methods have made rapid progress.
Currently, the highest resolution of a cryo-EM reconstruction is 1.9 Å (4, 5) which is the
structure of double-layered two-dimensional aquaprin-0 crystal achieved by electron
crystallography. However, most 3D cryo-EM structures have lower resolution. Three different
3DEM methods are used: single-particle analysis, electron tomography, and electron
crystallography. Single-particle analysis is the primary method I used.

Single-Particle Analysis
“Single-particle” analysis is suitable to solve the 3D structure of biological macromolecules that
are freestanding (non-crystalline) and have regular or consistent structure from particle to
particle. The particles could be symmetric particles, such as viral capsids, or asymmetric
particles, such as ribosomes. In theory, atomic resolution can be achieved if sufficient numbers
of particle images are used (6). The sample particles have, or are assumed to have, identical 3D
structure, but lie on the grid in different orientations (i.e. view directions). A large number of 2D
particle images are collected, images are processed, and a 3D reconstruction obtained.
The 3D reconstruction is usually computed as follows: 2D project images of the sample
particles are picked from the micrographs, and 2D images are normalized and contrast transfer
function are corrected (Fig. 2.3, step 9). The origin (center of the particles) and orientation (the
view direction) of each imaged particle are determined (Fig. 2.3, steps 10-12). The 3D
reconstruction is calculated, then this reconstruction is used as the initial structure model for the
next iteration to match and refine the origins and orientations of the imaged particles and then get
a more accurate three-dimensional structure model, and these steps are repeated until the
calculations converge and no improvements are observed (Fig. 2.3) (3). Many software packages
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for single-particle analysis software exist, such as Bsoft (7), PFT3DR (8-10), EMAN (11, 12),
SPIDER (13, 14), XMIPP (15), AUTO3DEM (16), FREALIGN (17), and IMAGIC (18). Bsoft
and PFT3DR were used to reconstruct poliovirus-Fab maps in the following chapters. The
highest resolution of a cryo-EM reconstruction by single particle analysis is 3.3 Å (5) and at this
high resolution, the amino acid side chain densities of the aquareovirus capsid proteins are easily
visible.
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Figure 2.3 Protocol for cryo-EM 3D reconstruction (3). Steps 1 to 3 are sample preparation; 4 to 6, microscopy; 7
to 12, image processing; and 13, interpretation (1) Sample should be purified to make the sample particles
distinguishable in the images. (2) 2 to 5 µl of sample is loaded to a carbon-coated grid and is blotted to produce a
very thin aqueous film. (3) The specimen is plunge frozen, usually in liquid ethane, to produce vitreous ice. (4) The
cryo-EM grid is stored in a cryo-storage dewar or transferred to TEM in a specialized “cold holder”, where it is
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maintained at liquid nitrogen or helium temperatures until images are recorded. The specimen is observed in TEM
and images are recorded. (5) To protect the specimen from radiation damage, low electron dose is applied. (6) The
recorded images are digitalized and checked to select good images with low astigmatism and drift. (7) Usually, each
particle image is extracted for single-particle analysis. (This step may not be necessary for an electron tomography
reconstruction.) (8) Particle images should be normalized and adjusted to be statistically similar, e.g., have same
background or average value. (9) For cryo-EM, under-focused micrographs provide more image contrast, which also
introduces image/contrast distortions. To obtain a high resolution of 3D reconstruction, this contrast transfer
function (CTF) and the natural signal decay with increasing resolution can be corrected by modeling
mathematically. (10) Translational and rotational alignments. Angles {φ, θ,ψ} and lengths {x,y} are determined
(19). (11) Computation of 3D reconstruction. (12) Various analysis techniques may be used to assess the quality of
the reconstruction. The resolution of the map usually is one criterium to determine if a reconstruction is satisfactory.
To refine the origins and orientations of the imaged particles, steps 10 to 12 should be repeated until the resolution
of the 3D reconstruction does not improve. (13) The results and interpretation of the data are written for publication.

Electron Tomography
Electron tomography is usually applied for naturally variable and/or highly complex biological
structures (20), such as non-regular (pleiomorphic) macromolecules (21, 22), supramolecular
heterogeneous assemblies, organelles and cellular fractions (23), isolated macromolecules to
cells and cell sections (3), or macromolecules in cell or tissues (24). Electron tomography
provides us the structural information at subcellular organization levels (25). The principles and
methodology of electron tomography are similar to the ones of single-particle analysis (3),
except here multiple images of the same specimen are recorded at many different angle. The
typical steps of electron tomography are 1) put the prepared cryo-EM sample in the TEM; 2) tilt
the samples typically in range +70º ~ -70º at 0.5º to 5º intervals and record an image at each step;
then 3) translationally and rotationally align the raw data to produce the 3D reconstruction.

23

Electron Crystallography
Some biological macromolecules can form two-dimensional (2D) crystals, especially membrane
proteins. In addition to 2D crystal, the electron crystallography technique also can be used to
solve the structure of biomolecules with helical symmetry. For a particle whose structure is
suitable to be solved by electron crystallography, it has translational symmetry in a plane.
Electron diffraction will occur when electrons pass through the 2D crystal and the electron
diffraction pattern is used to determine the amplitude. The phase is determined by the 2D
images. The density of molecules is obtained via the inverse Fourier transform and, hence, the
3D reconstruction can be acquired. In 1990, electron crystallography was applied to solve protein
structure – the structure of bacteriorhodopsin (26).

2.4 Fab Labeled Virus
Cryo-EM of antibody-labeled capsids provides a way to identify epitopes, e.g. (27-30). Virus is
mixed with monoclonal or monospecific antibodies, and the resulting complexes are imaged
followed by three-dimensional (3D) reconstruction of the complex. The use of antibody-binding
fragments (Fabs) is preferred to avoid particle aggregation (from antibodies binding multiple
particles) or to avoid large masses of disordered protein that may interfere with orientation
finding (from antibodies binding to only one epitope). After successful 3D reconstruction of the
complex, atomic coordinates of the antigen and Fab are fitted into the 3D density. (Usually
coordinates of any Fab are sufficient.) By fitting antigen and antibody coordinates into the map,
the epitope on the capsid surface can be identified (30).
We studied poliovirus cell-entry transition via three different monoclonal or
monospecific antibodies to VP1, which bind to the residues 24-40, 39-55, or 93-103 of VP1. P1
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Fab binds near the N-terminus, at residues 24-40 (see Chapter 3). C3 Fab binds a loop between
the B and C β-strands (BC loop), residues 93-103 (32) (see Chapter 4). The last Fab I used binds
residues 39-55 (33, 34) (see Chapter 5).
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Chapter 3. An Externalized Polypeptide Partitions Between Two Distinct Sites
on Genome-Released Poliovirus Particles

3.1 Introduction
Poliovirus, the prototypic member of the picornavirus family, is one of the major model systems
to study non-enveloped cell-entry mechanisms. Both the virus and its cellular receptor,
poliovirus receptor (Pvr, also known as CD155), are extensively characterized and structurally
defined (1-8). Like other picornaviruses, the poliovirus capsid is composed of 60 copies of four
capsid proteins (VP1, VP2, VP3, and VP4), arranged with icosahedral symmetry (Fig. 1). VP1,
VP2, and VP3 have a β-jellyroll topology and form prominent features known as the “mesa”,
“canyon”, and “propeller” on the outer surface of the capsid (Fig. 1). VP4 lies in an extended
conformation on the inner surface of the capsid, as do the N-terminal segments of VP1, VP2, and
VP3. The capsid surrounds an approximately 7500-nucleotide, single-stranded RNA genome.
During cell entry, the binding of “native” virus (sedimentation coefficient 160S) to
CD155 initiates conformational rearrangements that lead to formation of the genome-containing
cell-entry intermediate (135S) particle (1, 9, 10). After uncoating (release of RNA into the host
cell), the resultant empty capsid shell sediments at 80S.
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Figure 3.1 Structural features of 160S and 135S particles. (Top) Prominent structural features on the exterior of
the 160S poliovirus particle (5). Fivefold (pentagon), threefold (triangle), and twofold (oval) symmetry axes are
labeled. A second threefold axis is labeled to show an asymmetric unit—the triangle formed with the fivefold and
two threefold axes as vertices. (The line connecting threefold axes passes through the twofold axis.) The asymmetric
unit is the unique portion of the structure. The rest of the structure (59 other equivalent portions) is made by
symmetry operations. (Bottom) Close-up view of four prominent structural features on the exterior of the 135S
poliovirus particle (13), with one symmetry-related copy of “propeller tip” and “bridge” labeled. The predicted
helices in the canyon are residues 42-52 from the N-terminus of VP1 (black wire diagram). The gray net is a cryoEM reconstruction. For both 160S and 135S particles, the mesa is formed solely by VP1, the canyon and propeller
by VP1, VP2, and VP3. The propeller tip is formed by the EF loop of VP2 and flanking polypeptide sequences
from VP1 and VP3. Each mesa is centered on a fivefold symmetry axis, and each propeller is centered on a
threefold symmetry axis.
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The conformational rearrangements that form the 135S intermediate involve irreversible
externalization of VP4 (which is myristoylated at its N-terminus (11)) and the N-terminal
extension of VP1 (which is predicted to form an amphipathic helix (12)) from the capsid interior;
externalization of these viral polypeptide sequences appears to facilitate poliovirus cell-entry (5,
12-18). These exposed sequences interact with—and in the case of the N-terminus of VP1 tether
particles to—artificial membranes (12, 19). The exposed sequences also insert into cellular
membranes during infection (16). Analyses of VP4 mutants show that VP4 plays a key role in
the formation and properties of virus ion channels and in uncoating (16). For VP1, residues 1-53
were predicted to be exposed on the capsid surface, with residues 54-71 linking the externalized
portion with the inner capsid surface; specifically, according to the model, the N-terminus of
VP1 extends through a small opening between adjacent VP1 subunits, bridges the canyon, and
emerges at the propeller tip (Fig. 1) (13). The N-terminal 31 residues were proposed to be mobile
or disordered, but located near the propeller tip, far from the fivefold axis (13). Uncoating is
accompanied by additional conformational changes in the virus particle that are reflected by the
presence of at least three forms of the empty capsid, or 80S particle, (20, 21).
Cryogenic electron microscopy (cryo-EM) of antibody-labeled macromolecular
complexes provides a way to map epitopes, (e.g. (22-26)). Antibodies are mixed with the
complex, and the resulting combination is imaged followed by three-dimensional (3D)
reconstruction. Monoclonal or monospecific antibodies are preferred because they provide
specificity for the selected epitope, which gives consistency in the 3D reconstruction. The use of
antigen-binding fragments (Fabs) is preferred to avoid formation of aggregates (e.g.
immunoprecipitation) and to avoid large masses of disordered protein that add noise and
interfere with orientation finding (from antibodies binding to only one epitope). After a 3D
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reconstruction of the Fab-labeled complex is computed, atomic coordinates of the antigen and
Fab are fitted into the 3D density. (Usually, coordinates of any Fab are sufficient.) In this way,
an epitope can be localized on the surface of the complex. Conformational changes can be
inferred if the epitope in question is exposed in one state but not another or if the epitope changes
position.
To understand the structural rearrangements associated with the N-terminal residues of
VP1, we determined 3D reconstructions from cryo-EM images of P1-Fab-labeled 135S and 80S
particles. Polyclonal antibodies raised against peptide 1 (P1) recognize amino acid residues 24 to
40 of VP1 (27). The epitope monospecificity of these antibodies allows the location of the P1
epitope to be tracked as the virus particle undergoes the conformational rearrangements
associated with cell entry and genome uncoating. We found that the P1 epitope is located on the
propeller tip of the 135S particle, which is consistent with the previously modeled position of the
N-terminus of VP1 (13). The P1 Fab binds to two sites on the 80S particle (one at the propeller
tip, one at the twofold axis), and individual particles were found to have Fabs bound to one of the
two sites or to both sites.

3.2 Materials and Methods
Preparation of viruses, 135S particles, 80S particles, and virus-Fab complexes.
Poliovirus virions (160S particles) were grown in a suspension of HeLa cells, harvested by
centrifugation and freeze-thawing, and purified by CsCl density-gradient centrifugation as
described previously (9, 28). Altered 135S particles were prepared via heat treatment (9, 13).
Briefly, a solution of 160S particles was diluted fivefold in prewarmed low-salt buffer (20 mM
Tris, 2 mM CaCl2, pH 7.5) and was incubated at 50 ºC for 3 min. (sample placed in ice water
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after incubation). P1 Fab was prepared from affinity-purified antisera raised against peptide P1
(27) by dialysis in 20 mM phosphate buffer and 10 mM EDTA (pH=7.0) and the ImmunoPure®
Fab preparation kit (Pierce, Thermo Fisher Scientific, Rockford, Illinois, USA).
In our experiments we used heat to induce the change from native (160S) particle to cellentry intermediate (135S) and RNA-released (80S) particles. 135S particles produced by heat or
obtained from infected HeLa cells 1) infect cells normally non-permissive for poliovirus
infection by 160S particles, 2) have lost VP4, 3) are similarly sensitive to proteolysis, and 4)
similarly react with antibodies to the N-terminus of VP1 (9). 80S particles produced by heat
share antigenicity, sedimentation properties, and protease sensitivity with empty particles that
accumulate within cells and, like those particles, have externalized both VP4 and genomic RNA.
Solutions of 135S particles (0.6 mg/mL) and P1 Fab (0.8 mg/mL) were mixed at room
temperature with an antibody-to-virus ratio of 600:1 (mole:mole). Thirty-four percent of the
imaged particles in the 135S sample were 80S particles, cf. (9). 135S and 80S particles were
readily distinguished by, respectively, the presence or absence of density corresponding to the
viral RNA. These 80S particles were used to solve the structure of the 80S-P1 complex.

Electron Microscopy
Thin films containing poliovirus complexed with P1 Fabs were suspended over holey carbon
films, vitrified, and imaged as described previously (29). A CM200 electron microscope (FEI,
Hillsboro, Oregon, USA) equipped with Gatan 626 cryoholder (Pleasanton, California, USA)
was used to record focal pairs of micrographs at magnifications of 38,000× at 120 kV.
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3D reconstruction
Particle images were extracted, processed, and normalized as described (5). Focal settings
ranged from 0.81 to 2.24 µm underfocus. Focal-pair images were computationally combined for
orientation determination but used separately for origin determination and computation of the 3D
reconstruction. A previous reconstruction (5) or a model determined via common lines (30) was
used to begin iterative model-based determination of orientations and origins. Origins and
orientations of the extracted particles were determined via the model-based technique of PFT2
(31), which was adapted to use phase and amplitude information in orientation selection (32). 3D
reconstructions were calculated via EM3DR2 (30, 33). Icosahedral symmetry was applied during
the reconstruction computations and orientation searches. Bsoft routines were used to assess and
correct for contrast transfer function (CTF) effects (34) via the algorithm by Conway and Steven
(35), but images within a focal pair were not combined during CTF correction. Spherically
averaged density plots were used to calibrate size (34, 36) against previously calibrated
structures (5) and a poliovirus X-ray crystal structure (37). 3D reconstructions were displayed at
contour levels designated by the number of standard deviations (σ) above the average map
density.

Classification of particles
Our initial 80S-P1 reconstruction showed two P1 Fab binding sites, and we sought to separate
particles by binding site. Using the UCSF Chimera package (38), we deleted Fabs via the
volume-eraser function, leaving structures with Fabs in only one type of site. The modified
maps served as the starting models for multiple-model-based classification, using a method
similar to that used by Heymann et al. (39). Each particle image was compared to a model
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projection from each state. For a particle to be selected, a minimum correlation-coefficient value
of 0.30 (for high- and low-pass Fourier filters of 90-1 Å-1 and 21-1–16-1 Å-1, respectively) was
used as well as a minimum difference (range 0.005–0.010) between the correlation coefficients
obtained from each form, i.e. a selected particle had to have a correlation-coefficient value of
0.30 or greater and be 0.005–0.010 higher than the value for the other 80S-P1 state. Fifty
percent of the total number of particles were assigned to one of the two forms. By using the
multiple-model-based classification method, we also attempted to classify the 80S particles into
three groups: one with Fab bound at the propeller tip, one with Fab bound at the twofold axis,
and one with Fab bound to both binding sites.
The Fab density in the 135S-P1 reconstruction was very low. We attribute this to a
combination of low occupancy due to the relatively low affinity of the Fab for the 135S particle
and to a reduction of density in the icosahedrally averaged reconstructions due to the flexibility
of the epitope in the 135S particle (13). A 135S map (5) and the original 135S-P1 map were
applied to classify the 135S particles, in the same manner as that used for the two forms of 80SP1 (described in the previous paragraph). However, in this case, the classification values were
used only to determine which particles from the previous (weak P1 Fab) set were used to
compute the final reconstruction. Orientations and origins determined previously—without
classification—were applied.

One-particle reconstruction
To assess Fab binding to individual particles, one-particle reconstructions (e.g. (40)) were
computed to a limit of 40-Å resolution. (A close-to-focus and far-from-focus image pair was
used to compute each “one-particle” reconstruction.) Icosahedral symmetry was applied during
computation of the one-particle reconstructions, as it was in the multiple-particle reconstructions.
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Central slices of these reconstructions were observed to assess whether Fabs were present and, if
so, where the Fabs were bound.

Modeling
C3 Fab coordinates (41) were used to model the virus-P1 interaction. Coordinates were fitted
“by-eye” into 135S-P1 and 80S-P1 maps via the UCSF Chimera package (38).

3.3 Results
We used antipeptide antibodies to the N-terminus of VP1 to locate this peptide in two key cellentry intermediates. Purified virions were heated at 50°C to produce a mixture of 135S and 80S
particles, and the particles were mixed with Fab fragments of a monospecific antibody raised
against a peptide (P1) corresponding to residues 24-40 of VP1 (27).
Micrographs (i.e. same fields-of-view) contained complexes of the Fab with both 135S
and 80S particles. These two particles were easily distinguished by the lack of internal density
corresponding to the viral RNA in the 80S particles. The two forms were separated during
particle image extraction (“boxing”) and used to compute separate 3D reconstructions.
Therefore, the imaging conditions for the 135S-P1 and 80S-P1 complexes are identical and are
not responsible for the observed differences between the complexes.
We computed the 3D structures of the 135S-P1 and 80S-P1 complexes by cryo-EM and
3D image reconstruction (Table 1, Figs. 2-4). Estimates for the resolutions of the two structures
based on Fourier shell coefficient analysis (using a 0.5 cutoff) were 12 Å for the 135S-P1
complex and 13 Å for the initial 80S-P1 complex (two other 80S-P1 reconstructions were
calculated to 18-Å resolution, see section “Two P1 Fab binding positions in 80S-P1 complex”
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below). The density corresponding to the Fab was weak in all reconstructions. However,
continual density corresponding to the Fab extends outwards from the capsid with no evidence of
a contrast fringe (e.g. the dark region immediately outside the capsid in Fig. 4A) that occurs at
contrast edges in underfocused images at low resolution. For comparison, we note that a
reconstruction of the virus-receptor complex, where the receptor is known to be bound at high
occupancy, also has continuous density extending from the virus particle into the receptor (Fig.
4D). We therefore conclude that the Fab fragments are bound and that the weak density can be
attributed to low occupancy, flexibility of the peptide epitope, overlapping monospecific Fabs, or
a combination of these factors. To make Fab density easier to see, we also computed 3D
reconstructions for both complexes at lower resolution (26Å for the 135S-P1 complex, 21Å for
the initial 80S-P1 complex).
Because of conformational dynamics or “breathing”, the N-terminus of VP1 (as well as
VP4) is transiently and reversibly exposed in 160S particles, and this exposure is temperature
dependent (42, 43). P1 Fab binding to 160S virions is, therefore, also temperature dependent—
occurring to a significant extent at 37°C but not 25°C (12, 27, 43). In contrast, P1 antibody
readily binds to 135S and 80S particles over a wide temperature range indicating the exposure
and accessibility of this sequence on these particle surfaces (12, 27).

One P1 Fab binding position in 135S-P1 complex
On the 135S particle, P1 Fab binds to a single position within the asymmetric unit (Figs. 1, 2AB). Fab density connects from the propeller tip outwards. In addition to having low occupancy
(~16%, Fig. 4C), the reduced size of the Fab domains at this contour level (Fig. 2A,B) suggests
that residues 24-40 of VP1 are flexible in the 135S particle or that monospecific Fabs bind to
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slightly different amino acid residues (section “Fab occupancy and Fab epitope flexibility” in the
discussion explains factors contributing to the small size and low density of the Fabs).

Table 3.1 Microscopy and image reconstruction data

Sample
135S-P1

a

80S-P1
(both binding sites)
80S-P1
(propeller tip only)
80S-P1
(twofold only)

Particle
imagesa
2110 c
10160c
5256
1132

Resolutionb (Å)
26d
12
21d
13
18

EMDB
ID
5282
5280
5284
5283
5286

1814

18

5285

Total number of images, divide by two for the number of image pairs (focal pairs). These images were extracted

from seven focal-pair micrographs, where the first image in the pair was taken closer-to-focus and the second image
farther-from-focus. The pixel size for the reconstructions was 1.83 Å. For the orientation and origin determination,
images were only corrected for phase-flipping effects of the CTF. For the final, published reconstruction, images
were fully deconvoluted for CTF effects and a signal-decay correction was also applied (see Materials and Methods
section).
b

Determined by the point at which the Fourier shell correlation (FSC) value reaches 0.5. For the FSC test, images

were only corrected for phase-flipping effects of the CTF.
c

The difference in the number of particles used is attibutable to classification of particles that matched best with a

model containing an Fab on the propeller tip (2,110) against a model without an Fab bound (see Materials and
Methods). The other reconstruction (10,160) was from iterative model-based orientation and origin refinement
against all 135S particles in the data set. In the latter, all particles that matched well were included.
d

Lower-resolution versions of the 12-Å 135S-P1 and 13-Å 80S-P1 maps were computed so that the bound Fabs

could be seen more easily.
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Figure 3.2 Stereo views of reconstructed 135S and 135S-P1 complex. (A) 135S-P1 complex (resolution 26 Å)
reconstruction at a contour level of 0σ. Fab coordinates (cyan) are shown with the variable domain fitted into the P1
density. The fitting shown here is only to provide an estimate of the average Fab position. In the Fab variable
domain, the volume occupied by the coordinates is significantly larger than the cryo-EM density, indicating that the
epitope is flexible. (B,C) Coordinates (wire diagram) of the 135S model (13) (1XYR, Protein Data Bank) fitted in
the 135S-P1 (B) and 135S (C) (13) maps (fine mesh). Coordinates for VP1 (blue), VP2 (yellow), VP3 (red) and
residues 42-52 of the N-terminus of VP1 (green) are shown.
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Figure 3.3 Views of reconstructed 80S-P1 complex. (A-C) Stereo views of 80S-P1 complex reconstructions. P1
Fabs bind 80S capsid (white) at the propeller tips (dark gray) and twofold axes (light gray). (A) The unclassified
80S-P1 (resolution 21 Å) reconstruction at a contour level of 0.2σ. (B,C) Reconstructions of 80S-P1 complexes
(resolution 18 Å) with Fab bound to the propeller tip (B) and with Fab bound at the twofold axis (C), both at a
contour level of 0.5σ. (D) Fab coordinates (ribbon structures) fitted into the two different binding sites in the 80SP1 map (mesh). The Fab bound to the propeller tip is shown in the left panel. The Fab bound at the twofold axis is
shown in the right panel. In both cases, the density in the antigen-binding domain (of the Fab) was not complete.
The fitting shown here is only to provide an estimate of where the Fabs might be positioned. The constant (nonantigen binding) domain of the Fab bound at the twofold axis is larger than the volume occupied by the ribbon
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model. The extra density likely results from twofold positioning of the epitope (but only one Fab can bind at a
time), the monospecific nature of the antibody, or the flexibility of the constant domain.

Figure 3.4 Binding of P1 Fab to poliovirus. Central slices from density maps of P1 Fab complexed with 80S
particle (A,B) and 135S particle (C) and poliovirus (160S form) complexed with poliovirus receptor (Pvr) (4) (D).
Highest densities are white. Arrows indicate P1 Fab-related density. Arrows indicate Fabs bound at the propeller tip
(unfilled arrowhead) or twofold axis (filled arrowhead). The 80S-P1 complex maps were computed from
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unclassified (A) and classified (B) particles. For (A); left, resolution 21 Å; right, resolution 13 Å. For (B); left, Fab
bound to the propeller tip; right, Fab bound at the twofold axis, both structures at 18-Å resolution. For (C), 135S-P1:
left, resolution 26 Å (from classified particles); right, resolution 12 Å (from unclassified particles). Relative density
estimates: a sphere of radius 3 pixels was centered on the designated spots (A, right panel) and the average density
computed. In the unclassified 80S-P1 map at resolution 21 Å (A, left), P1 Fab at the propeller tip (unfilled
arrowhead) has 15% of capsid density and P1 Fab at the twofold axis (filled arrowhead) has 24%. In the classified
80S-P1 maps at resolution 18 Å (B), P1 Fab bound to the propeller tip (unfilled arrowhead) has 25% of capsid
density (B, left), and P1 Fab bound at the twofold axis (filled arrowhead) has 23% (B, right). In the 135S-P1 map at
resolution 21 Å (C, left), P1 Fab has 16% of capsid density. Insets, a smaller, unlabeled version of the figure, given
to allow the faint Fab density to be seen more easily. (D) Control image showing Pvr attached to poliovirus 160S
particle (4). Bars, longer bar for larger images, shorter bar for inset images. (Note: a faint bit of density appears on
the twofold axes in panel B (left). This faint density does not appear in the surface rendering in Fig. 3B and
therefore is much lower than the density observed at the propeller tip. We attribute this faint density to errors in
classification and to artifacts that often appear along symmetry axes in reconstructions.)

Two P1 Fab binding positions in 80S-P1 complex
Inspection of the initial 80S-P1 map showed that P1 Fabs bound to two distinct areas on the
capsid (Figs. 3A; 4A). The P1 Fab at the propeller tip in the 80S-P1 structure bound to the same
site as in the 135S-P1 complex. A second Fab bound at the 80S-P1 twofold axis. We used
classification methods to determine whether the two states were found on the same particles or if
particles were in one state or the other.
We found that 80S-P1 particles with Fabs bound to the propeller tip or twofold axis could
be separated by the position of the bound Fab (Fig. 3B-D, 4B). Therefore, the population of
80S-P1 particles exists in at least two states with the P1 epitope located at one of the two binding
sites: the propeller tip (Figs. 3B; 3D,left; 4B,left) or the twofold axis (Figs. 3C; 3D,right;
4B,right). Although we cannot rule out that some “cross-contamination” in the propeller-tip and
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twofold-axis data sets exists, the Fab density for each was clearly dominant in one form or the
other (Fig. 3B,C).
In the particles with Fab at the twofold axes, the Fab-related density shows a direct
connection to the twofold symmetry axes of the capsid (Fig. 3D). The density for the Fab at the
twofold axes is twofold symmetric and is closer to the size of an Fab than is the density at the
propeller tips of either the 135S-P1 or the 80S-P1 structures. Note, however, that the density for
the constant domain is larger than needed, indicating either flexibility in the epitope being bound,
overlapping monospecific antibodies, or that the two copies of the epitope at this site (which
could be contributed by either of two twofold related copies of VP1) are oriented slightly
differently.
To determine whether P1 epitopes can occupy simultaneously both locations on the same
particle, we attempted to use correlation-based classification to separate the 80S-P1 particles into
three classes: propeller-tip bound Fab, twofold-axis-bound Fab, and Fab bound to both.
However, the number of Fabs bound per particle was relatively low (Fig. 4A,B), which gave
little contribution from bound Fab in the noisy particle images and thus prevented clear
discrimination among these three classes. (Note that the reconstruction showing Fabs bound to
both sites (Figs. 3A, 4A) was an average structure of all selected 80S particles prior to
classification.)
Because the classification experiment failed to give a conclusive answer, we decided to
compute one-particle reconstructions. One-particle reconstructions are 3D reconstructions
computed from one image of a particle. Although 3D reconstructions require multiple views of
an object, one-particle reconstructions are possible for objects with icosahedral symmetry
because one view has 59 other symmetry-related views. We computed one-particle
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reconstructions to only 40-Å resolution because of the high noise level that arises from the
limited averaging implicit in one-particle reconstructions. Several reconstructions showed Fabs
bound to both the propeller tips and twofold axes of 80S particles (Fig. 5C). Other structures
showed Fabs bound to either the propeller tips or twofold axes (Fig. 5A,B). Thus, these
reconstructions demonstrated the existence of 80S particles where P1 epitopes are located at both
the propeller tips and twofold axes simultaneously.
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Figure 3.5 One- or Eight-Particle Reconstructions of 80S-P1 complexes. Arrows indicate Fab bound at the
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propeller tip, and stars indicate Fab bound at the twofold axis. (A, B, C) Central slices of one-particle
reconstructions of 80S-P1 complex with P1 Fab bound at the propeller tip (A), the twofold axis (B) and at both
binding sites (propeller tip and twofold axis) (C). (D) Central slices of eight-particle reconstructions of 80S-P1. The
same particle images that were used to make the one-particle reconstructions in A-C were combined to give the
structures seen here. From left to right: eight-particle reconstruction of 80S-P1 with P1 Fab bound at the propeller
tip; eight-particle reconstruction of 80S-P1 with P1 Fab bound at the twofold axis; mixed eight-particle
reconstruction (four particles of 80S-P1 with P1 Fab bound at the propeller tip and four particles of 80S-P1 with P1
Fab bound at twofold axis); and eight-particle reconstruction of 80S-P1 with P1 Fab bound at both binding sites. E)
Control structures. Central slices of one-particle reconstructions computed from a different poliovirus-antibody (C3)
complex (top row) (J. Lin et al., unpublished) and the poliovirus-Pvr complex (bottom row) (4). The left three panels
in each row are one-particle reconstructions and the rightmost panel is an eight-particle reconstruction. The oneparticle reconstructions show bound Fab (top row) or bound receptor (bottom row). The C3 antibody binds very
tightly to poliovirus 160S, 135S, and 80S particles (12) and Fabs were found to bind to the tips of the mesa (J. Lin et
al., unpublished). Pvr binds to one side of the propeller tip and bridges the canyon (4). In A-E, the monotone gray
circular center seen in some slices was added artificially to mask very high positive or negative density values at the
center of the 3D reconstruction—a common artifact in one-particle, icosahedral reconstructions.

3.4 Discussion
In part because crystallization of picornavirus cell-entry intermediates has been unsuccessful,
cryo-EM studies provide unique potential for structurally characterizing the entry process, e.g.
(4-8, 13, 20, 21, 44-48). During viral entry, receptor-mediated conformational changes result in
the externalization of the myristoylated protein VP4 and the N-terminal extension of VP1 (12),
both of which become associated with membranes (12, 16, 19). In subsequent steps, unknown
triggers result in the externalization of the viral RNA and its translocation across a membrane to
gain access to the cytoplasm for replication (see (1, 17, 18)).
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Because the externalized peptides are thought to play a role in internalization, genome
release, and translocation of the genome across membranes (1, 18), a knowledge of the location
of the externalized portion of VP1 is key to the refinement of models for the entry process. A
previously published study of the 135S particle and a 135S particle in which the first 31 residues
of VP1 were removed by proteolysis suggested that the N-terminus of VP1 is located at the
propeller tip (13). Three-dimensional reconstructions of the 80S particle also suggested that the
N-terminus of VP1 was located at the tips of the propeller in some but perhaps not all of the
particles (20) (see section “N-terminus of VP1 makes conformational changes during uncoating”
below). However, the 135S and 80S reconstructions lacked density for the N-terminus of VP1
(presumably because it is flexibly tethered to the virion). In this study, we took advantage of the
availability of antibodies against the N-terminal extension of VP1 to probe its location in the
135S and 80S particles. The results are consistent with the results of the previous studies, but
show that this peptide can be located in two different locations in the 80S particles. Surprisingly,
these results also indicate that the same peptide in some cases can occupy two different positions
in the same 80S particle, which represents a significant break from icosahedral symmetry for
these particles.

Specificity of P1 Antibody
Evidence strongly suggests that the antibody raised against peptide P1 only recognizes amino
acid residues 24 to 40 of VP1 and does not bind non-specifically to other regions of the 80S or
135S particles. Only one site is bound in 135S particles (Fig. 2A). In 80S particles, two sites are
occupied, either one or the other or both (Figs. 3, 5). Anti-P1 sera only recognized the P1 peptide
(VP1 residues 24-40), VP1, and the carrier protein to which the P1 peptide was attached; no
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other peptides from VP1 were recognized, and VP2 and VP3 were unrecognized (27).
Recognition of anti-P1 sera was blocked by competition with P1 (27). Before its use in this
study, the antisera was affinity purified with the P1 peptide, thereby removing reactivity with the
carrier protein.

Fab occupancy and Fab epitope flexibility
Because 3D reconstructions of freestanding particles are averages of multiple particles that are
assumed to be similar, sub-volumes with lower average density must indicate lower occupancy,
flexible domains, or both. If the low-density sub-volume has the full shape of a protein domain,
then the domain must be rigidly positioned but have lower occupancy (i.e. not all positions in all
particles have the domain). If the lower density region is smaller or larger than the full shape of
the domain, then the domain must be flexible or have multiple rigid conformations. Overlapping
regions will have the highest densities. The higher the occupancy, the larger a flexible domain
will appear. Hence, observation of a small low-density portion of the Fab volume at the
propeller tip in 135S-P1 (Fig. 2A) or 80S-P1 (Figs. 3A-B;D,left) indicates not only low
occupancy, but that the P1 Fab at the propeller tip is located in multiple positions in the 135S and
80S particles.
If some parts of a structure have higher resolution than other parts, then the lowerresolution is another indication of flexibility. We observed this pattern for the 135S-P1 and 80SP1 maps. Sections show a well-resolved capsid with fuzzy, poorly resolved density outside of
the capsid where Fab is bound (Fig. 4A,C, right panels). “Local” resolution tests (resolution of
small subvolumes of the reconstruction) confirmed the observation of higher resolution in the
capsid and lower resolution in the Fab regions (data not shown).
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Each voxel (pixel volume) in a 3D reconstruction shows the average density (at the given
xyz position) for the particles used. Therefore, density averages for flexible components will be
more diffuse than for rigid components. Furthermore, the higher the resolution of a 3D map, the
more unlikely flexible regions will be observed. If the 3D reconstruction is computed at lower
resolution, flexible regions will be more apparent. This was the case with our 135S-P1 and 80SP1 maps; Fab density was more easily observed at, respectively, 26- or 21-Å resolution than at
12- or 13-Å resolution (Fig. 4A,C). Even at the lower resolutions, Fab density was seen at
relatively low contour levels in surface renderings (Figs. 2A-B; 3A) and faintly in density
sections (Fig. 4A,C).
Continual density extending outwards from the capsid is additional evidence that Fabs are
bound (Fig. 4). In many places, a dark region is located immediately outside the capsid density
(e.g. Fig. 4A). This region is an effect of defocusing (specifically underfocusing) that is
routinely performed during cryo-EM to enhance contrast. In incompletely corrected twodimensional images and 3D image reconstructions, defocusing causes a fringe of intensity of
opposite contrast at edges. No fringe is found at the Fab-binding sites, indicating the presence of
continuous density. A similar connection was observed for receptor-bound particles (Fig. 4D).

Monoclonal vs. monospecific antibodies
An alternative reason for the appearance of flexible epitopes is that a monospecific, not
monoclonal, antibody to residues 24-40 of VP1 was used. A monospecific (or polyclonal)
antibody to this region could result in slight differences in binding among the Fabs bound. The
average structure observed in the reconstructions would then have the appearance of a flexible
epitope that had a monoclonal antibody bound.
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For 3D cryo-EM reconstructions, monoclonal antibodies are usually preferred over
monospecific antibodies because of the overlapping binding sites. Our observation of two
binding sites in 80S particles suggests that monospecific antibodies—to a short peptide—may be
valuable probes for assessing conformational changes. We do not know if the same amino acids
bind to the monospecific antibody at the propeller-tip and twofold-axis epitopes. Even if the
same amino acids are bound, the same Fab (with identical variable region) may not bind because
the amino-acid conformation may differ. Therefore, a monoclonal antibody that binds to one
conformation may not recognize the same amino acid residues after the conformational change.
In this situation, one might erroneously conclude that the epitope was not exposed. Monospecific
antibodies to short peptides may better recognize conformational differences and still provide
enough specificity for structurally consistent 3D density maps. The appearance of a flexible
epitope may always result from the use of monospecific antibodies.

N-terminus of VP1 is located near the propeller tip in 135S and 80S particles
The 3D reconstructions of 135S-P1 and 80S-P1 (Figs. 2A,B; 3A,B; 3D,left) show that P1 Fab
binds to the propeller tip in 135S and 80S particles, with P1 Fab bound at the propeller tip alone
or at both binding sites. These observations are consistent with existing models of 135S (13) and
80S (20) and with a difference map of 135S minus 135SΔN31 (13), which placed the P1 epitope
(residues 24-40, (27)) near the propeller tip. For example, residues 42-52 of VP1 (modeled as an
α-helix) are close to the propeller tip (Fig. 1,bottom; Fig. 2B,C) and difference density was
observed at the propeller tip (13).
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Non-synchronous changes in 80S particles
As in many other nonenveloped viruses, poliovirus capsid proteins are organized to form an
icosahedrally symmetric shell. An important question in icosahedral virus assembly and
disassembly is whether all copies of pertinent protein domains participate synchronously in the
conformational changes associated with these processes and whether significant deviations from
icosahedral symmetry can exist within an individual particle during conformational transitions.
Because cryo-EM structures are averages of many particle images, structural features that are
conveyed at lower resolution than the rest of the structure are likely caused by conformational
variability among the population of particles. But, for symmetric particles such as poliovirus,
these differences might be attributable to variations between particles that, individually, are
symmetric. Here, we provide direct evidence that significant deviations from icosahedral
symmetry—for portions of capsid proteins—do exist within the same particle. The observation
of epitopes in two concurrent positions shows that significant portions of the capsid proteins
within the icosahedral shell may have deviations from icosahedral symmetry and, hence, do not
change conformation synchronously. Such deviations may be biologically significant during
viral transitions.
80S-P1 particles with both Fab binding sites (Fig. 5C; 5D,right) show that the N-termini
of VP1 are simultaneously located at two different sites (the propeller tips and twofold axes) on
the same particle. This 80S state may indicate that during uncoating, the corresponding
conformational change in the capsid is a gradual process. In other words, for an individual
particle, the 60 copies of the N-terminus of VP1 are not required to change their conformations
at the same time or in the same way.
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As stated, the Fabs used in this experiment were monospecific, not monoclonal.
Therefore, although P1 Fabs all bind within residues 24-40 of VP1, the Fabs bound at the
propeller tips and twofold axes may recognize different amino-acid residues within the P1
epitope. However, the straight-line distance between antigen-binding sites on the propeller tip
and the twofold axis is 52 (± 1) or 62 (± 0.4) Å, for the two closest twofold axes. (Measurement
is based on placement of Fab coordinates into the Fab density, e.g. Fig. 3D). Assuming that 1)
each residue occupies a linear distance of 3.8 Å along the polypeptide chain, 2) residues 24-40
are not in a straight-line conformation, and 3) each Fab binds several residues within the P1
peptide, P1 Fab binding to the propeller tips and twofold axes likely cannot result from two Fabs
binding to different ends of the P1 epitope from one VP1 subunit. The seemingly simultaneous
binding of P1 Fabs to different sites on the same 80S particle (in the icosahedrally averaged
structure) most likely occurs because P1 epitopes from different VP1 subunits lie at a twofold
axis or at a propeller tip.
We hypothesize that deviations from icosahedral symmetry are more likely to occur in
extensions of the polypeptide chains (e.g. N-termini, C-termini, or large loops) that are not
critical to interactions within the core shell structure. For example, the 53-residue N-terminus of
VP1 could lie in different conformations on the capsid surface without necessarily disturbing
interactions between the β-jellyroll cores of VP1, VP2, and VP3, which form the shell. If
interactions of cores in one portion of the capsid are altered, we hypothesize that these changes
would be more likely to propagate rapidly throughout the capsid shell. In our case, the
symmetry-averaged cores of the VP1-3 subunits were resolved at 13-Å or better, indicating that
the core structures of 80S particles were well ordered.
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N-terminus of VP1 makes conformational changes during uncoating
The transition of VP1 residues 24-40 from the propeller tip to the twofold axis appears to be part
of uncoating. Besides having the same binding site as in the 135S-P1 complex, P1 Fabs bind to a
second site in 80S-P1—at the twofold axis—indicating either that conformational
rearrangements occur during uncoating or that an additional variable, characteristic of the
multiple-form 80S particle (20, 21), exists. Because only one P1 Fab at a time can bind to
residues 24-40 of VP1 (see previous section), our results show that 80S particles contain the
epitope in one or both of two locations.
The observation that peptide 1 (P1) changes position and perhaps conformation during
the 135S-to-80S transition is consistent with previously published immunoprecipitation
experiments that showed a change in the N-terminus of VP1 between these two states. Titers of
P1 monospecific and monoclonal antibodies and a monospecific antibody against peptide 0 (P0,
residues 7-24) for 80S particles differed significantly from the corresponding titers for 135S
particles (12). The transition from the 135S particle to the 80S particle also involves the
externalization of the RNA genome of the particle, and, interestingly, the new position for the P1
peptide is very close to the position where RNA was shown to be released from the particle
(21)—suggesting that the movement of the peptide may play a role in RNA release (often
referred to as “uncoating”) during infection.
Previous studies have shown at least three distinct forms of heat-derived 80S particles
(20, 21). In these studies, the 80S particles from preparations heated at 56 ºC for shorter times
had increased numbers of particles in the conformation labeled the “early” form (80S.e).
Conversely, samples heated for longer times showed increased numbers of the “late” form
(80S.l). Because both 80S.e and 80S.l were seen by Levy et al. (20) at all time points, even their
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4 min. incubation, the 80S particles in this study are also likely in these two states. Our sample
was prepared at a lower temperature (50 ºC) for a relatively short time (3 min.). These conditions
are typically used to produce 135S particles, but even this mild treatment typically produces a
significant number of 80S particles (9).
We compared the 80S.e and 80S.l maps (20) to our 80S structures but were unable to
make satisfactory distinctions, i.e. the correlation coefficients were nearly identical.
Nevertheless, Levy et al. (20) showed differences between 80S.e and 80S.l in a density feature
that is ascribed to a predicted helix spanning residues 41-53 from VP1 in the 135S structure (13).
If this sequence assignment is accurate, it would place the residues corresponding to the P1
epitope at the tip of the propeller, as observed in this (Figs. 2,3) and a previous (13) study.
Density for the helix is weaker in the 80S.e reconstruction than helix density in the 80S.l or 135S
reconstructions, implying that some fraction of the helices (and perhaps the P1 epitopes as well)
have moved in the 80S.e particles. The moved segments may be located at the twofold axes and,
therefore, are responsible for the Fab binding at the twofold axes that we observed. Both 80S.e
and 80S.l reconstructions had holes in the shell that suggested the viral RNA may be released
near a twofold axis (20). A third 80S intermediate actually showed RNA leaving the capsid near
the twofold axis at a site that corresponded to these holes (21). Because our experiment was
carried out under different conditions from those used by Levy et al. (20), we cannot rule out the
possibility that our results represent additional conformations of 80S particles not seen in the
previous studies (20, 21).
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Canyon-exit model
During cell entry, native poliovirus (160S) binds to its receptor, which stimulates conversion to
the 135S cell-entry intermediate particle (12). During this transition, the membrane-binding
entities, VP4 and the N-terminus of VP1, are externalized. Externalization of these proteins
requires conformational adjustments in the capsid. Based on hypothesized parallels between the
uncoating processes of human rhinoviruses and poliovirus, one model proposes that receptor
binding induces formation of a channel along the fivefold axes, and that VP4 and the N-terminus
of VP1 exit the capsid through this channel (44, 48, 49). In an alternative (canyon-exit) model,
VP4 and the N-terminus of VP1 exit the capsid at the base of the canyon (5, 13). Our structures
of virus-antibody complexes are consistent with the latter model.
The 135S-P1 reconstruction reported here supports the “canyon-exit” model by providing
more evidence that at least a portion of the externalized N-terminus of VP1 locates at the
propeller tip. The alpha helix proposed for residues 42 to 52 of VP1 is very close to the P1 Fab
binding site at the propeller tip, close to the canyon and the threefold axis (Fig. 1 and Fig. 2B),
which is consistent with the P1 epitope (residues 24-40) being located nearby and, hence, that the
N-terminus of VP1 is at the propeller tip, as modeled by Bubeck et al. (13) for 135S particles.
Our results are also consistent with a difference-density map, between V8-protease-cleaved 135S
and unmodified 135S particles, that showed difference-density at the tip of the propeller (13).
P1 Fab was also bound at the propeller tip in 80S-P1 particles. This is consistent with the
model of the 80S structure by Levy et al. (20). The Fab density bound at the propeller tip was
highest near the propeller tip (Fig. 2A-B; 3A-B,D,left), indicating that P1 Fab was most
constrained where it is bound to the capsid. The density volume of P1 Fab bound at the propeller
tip is smaller than that of the P1 Fab bound at the twofold axis (Fig. 2A-B; 3), which indicates
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the N-terminus of VP1 has more flexibility at the propeller tip than at the twofold axis. The
increased flexibility at the propeller tip may be necessary for the N-terminus of VP1 to become
imbedded in the membrane to prepare the virus for uncoating. The more rigid twofold-axis
position may be required for or be a consequence of RNA release.
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Chapter 4. Flexibility of the BC loop of the Poliovirus Capsid Protein VP1
During Cell Entry

4.1 Introduction
The poliovirus capsid is composed of 60 copies each of four capsid proteins (VP1, VP2, VP3,
and VP4), arranged with icosahedral symmetry (Fig. 4.1), surrounding an approximately 7500nucleotide, single-stranded RNA genome. VP4 and the amino-terminal segments of VP1, VP2,
and VP3 lie on the inner surface of the capsid with extended conformations. The external surface
of the capsid is constituted of VP1, VP2, and VP3.

Figure 4.1 Structural features of 160S particle. Prominent structural features on the exterior of the 160S
poliovirus particle (1), with an expanded representation showing the core β-jellyroll subunit and BC loop of VP1 (2)
at a tip of the star-shaped “mesa”.

During cell-entry, poliovirus (sedimentation coefficient, 160S) binds to its receptor,
CD155, which initiates conformational rearrangements and forms the cell-entry intermediate
(135S) particle. After RNA is released into the host cell, the empty poliovirus capsid sediments
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at 80S. The conformational rearrangements during the 160S-to-135S transition involve
irreversible externalization of VP4 and the N-terminal domain of VP1 (3-5). Poliovirus is an
excellent model system to study cell-entry mechanisms of non-enveloped viruses (6). Studies of
these conformational changes will aid understanding of cell entry of picornaviruses and perhaps
of other non-enveloped viruses (7, 8).
A loop connecting the B and C β-strands of the VP1 β-jellyroll (“BC loop”) is located at
each tip of the star-shaped mesa surrounding the particle fivefold axes (Fig. 4.1). As shown by
several studies, this loop (residues 93-103) is a major antibody-neutralizing site (9-16). One of
the neutralizing antibodies that recognize this loop is the C3 monoclonal antibody, which was
generated by immunizing mice with 80S poliovirus particles (10). This monoclonal antibody
binds 160S, 135S, and 80S particles (3).
A crystal structure of the Fab fragment of this antibody with a peptide corresponding to
residues 93-103 has been reported (17). The structure of the peptide in the complex differs
significantly from the structure of the peptide in the BC loop of the 160S particle, suggesting that
the loop is sufficently flexible to change structure upon antibody binding. This observation
suggests the question of whether the same phenomenon occurs when the antibody binds in an
assembled particle.
With the exception of the 160S particle (2, 18, 19), atomic-resolution structures of
poliovirus cell-entry intermediates have been elusive, and fitting of atomic structures into density
maps produced by cryogenic electron microscopy (cryo-EM) has been the only method to
approach the goal of understanding poliovirus transitions at near-atomic detail.
To track the location of the BC loop in the three cell-entry states, we mixed the Fab
fragment of the monoclonal C3 antibody with 160S, 135S, and 80S particles, and structures of
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the respective complexes were solved by cryo-EM. The resulting structures of 160S-C3, 135SC3 and 80S-C3 particles showed that the BC loop changes radius significantly (~ 7 Å) and twists
slightly (15°) during the 160S-to-135S transition, with little further change in the 135S-to-80S
transition. The locations of C3 in the 160S-C3, 135S-C3 and 80S-C3 maps are consistent with
the positions of the BC loop in X-ray crystal structures of 160S particles (2, 18, 19) and in
pseudo-atomic models of the 135S (1, 4) and 80S (20) particles. Our results suggest that the
conformation of the BC loop is affected by antibody binding.

4.2 Materials and Methods
Preparation of viral and Fab complex.
Poliovirus virions (160S particles) and C3 Fab were prepared as described previously (17, 21,
22). Altered 135S particles were prepared via heat treatment (50 ºC for 3 min.) of 160S particles
in low-salt buffer containing 2 mM CaCl2, as described previously (4, 22). Equal volumes of
160S-particle (3.9 mg/ml) and C3-Fab (1.7 mg/ml) solutions were mixed on ice, giving an
antibody to virus ratio of 74:1. A similar ratio was used to mix 135S particles and C3 Fabs, also
on ice. Some 80S particles were found in the 135S-C3 sample (22) and were used to reconstruct
the 80S-C3 structure.

Electron Microscopy
Mixtures of poliovirus (160S or 135S) and C3 Fab were suspended over holy carbon films,
vitrified, and imaged as described previously (23). A CM200 electron microscope (FEI,
Hillsboro, Oregon, USA) equipped with Gatan 626 cryoholder (Pleasanton, California, USA)
was used. Focal pairs of micrographs were recorded at magnifications of 38,000× at 120 kV.
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3-D reconstruction
Particle images were extracted, processed, and normalized as described (1). Focal settings
ranged from 0.73 to 1.77 µm underfocus. Focal-pair images were computationally combined for
orientation determination but used separately for origin determination and computation of the 3D
reconstruction. A model determined via common lines (24), a previous reconstruction (1), and a
135S-C3 map were used to begin iterative model-based determination of orientations and origins
for the 160S-C3, 135S-C3, and 80S-C3 reconstructions, respectively (25). Bsoft routines were
used to assess and correct for contrast transfer function (CTF) effects (26) via the algorithm by
Conway and Steven (27), but images within a focal pair were not combined during CTF
correction. Spherically averaged density plots were used to calibrate size (26, 28) against
previously solved structures (1) and a poliovirus X-ray crystal structure (2).

Modeling
Atomic coordinates for the C3 Fab (17) (1FPT in Protein Data Bank) were first fitted manually
(“by-eye”) into 160S-C3, 135S-C3, and 80S-C3 via UCSF Chimera package (29). Next, a coreweighted, rigid-body fitting algorithm, implemented in CHARRM (30), was used to refine the
fits. The full Fab and the antigen-binding or variable domain were refined separately. Each of
the five Fabs was fitted separately to one of the five tips of one mesa. Symmetry was applied via
the UCSF Chimera package (29) so that a single Fab binding site contained five overlapping sets
of fitted coordinates for each Fab binding site. Then the overlapping coordinates were averaged
and that average is the fit reported here. The C3 Fab coordinates included a peptide antigen made
of residues 93-103 of poliovirus VP1 (17). Residues 97-102 were bound to the Fab in the binding
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cleft of the C3 antigen-binding domain, and we compared the positions of these six residues to
the corresponding residues in 160S crystal structure (2) and the 135S pseudo-atomic model (4).
Using model and fitted coordinates, we used the match alignment function in UCSF Chimera
(29) to determine the shift and twist of the BC loop between the 160S and 135S models and the
shift and twist between the peptide antigen in the 160S-C3 and 135S-C3 fitted coordinates. This
shift and twist was along an axis determined by the algorithm.

4.3 Results
We computed three-dimensional (3D) reconstructions of the 160S-C3, 135S-C3, and 80S-C3
complexes by cryo-EM (Table 4.1). The resolutions of the maps ranged from 9 (for 135S-C3,
which was calculated using 9810 particles) to 22 Å (for 80S-C3, which was calculated using 238
particles). 135S and 80S particles were present in the same fields-of-view. These two particle
types were picked out separately (from digitized micrographs during particle-image extraction or
“boxing”, see Methods), and these two data sets were used to compute separate 3D
reconstructions.
The 3D reconstructions showed that, as expected, C3 Fab binds to the tip of the mesa–
where the BC loop was modeled in the 160S (2), 135S (4), and 80S (20) particle states (Fig.
4.2A-D). Five C3 Fabs surround each mesa, giving it the appearance of a five-petaled flower.
C3 Fab density has the same intensity as poliovirus density (Fig. 4.2E), indicating full or nearly
full occupancy of all 60 binding sites per virus. The antigen-binding domain in the 135S-C3
density map (Fig. 4.2E) shows the appearance of β-sheets, indicating that the bound Fab is well
ordered.
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Table 4.1 Microscopy, image reconstruction, and modeling data

Sample
160S-C3
135S-C3
80S-C3
a

Pixel
size (Å)
1.82
1.84
1.84

Particle
imagesb
4184
9810
238

CTF
correctionc
full
full
phases only

Resolutiond (Å)
11.1
9.1
22

EMDB
IDe
5291
5292
5293

focal pairs, first image taken closer-to-focus, second image farther-from-focus

b
c

Micrograph
pairsa
6
2
7

Total number of images, divide by two for the number of image pairs (focal pairs)

Correction for the final, published reconstruction: full, deconvolution of CTF and correction for decay; or, phases-

only, corrected only for the phase-flipping effects of the CTF.
d

Data set split in two, reconstructions computed and compared via Fourier shell correlation. Resolution determined

by the point at which the Fourier shell correlation value reaches 0.5, for reconstructions computed from images were
only corrected for phase-flipping of the CTF.
e

Identification code of density map in EM Data Bank
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Figure 4.2 Binding of C3 Fab to poliovirus. (A) Cryo-EM structures of 160S-C3 (left), 135S-C3 (middle), and
160SC3 (right). Radial coloring is applied to the surface rendering-density closest to the center of the particle is
orange, density farthest from the center is gray. Here, poliovirus capsids are shown in orange and C3 Fabs are shown
in gray. C3 Fab fitted in 160S-C3 (B), 135S-C3 (C) and 80S-C3 (D) maps. Upper figures show top views, bottom
figures show side views. C3 Fab coordinates (17) were fitted into one mesa-bound Fab (black ribbon). Fine mesh is
surface rendering of 3D reconstruction. All maps contoured at 0.5σ. (Contour levels designated by the number of
standard deviations (σ) above the average map density.) (E) Center slices from density maps of C3 complexed with
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160S (left) 135S (middle) and 80S (right). 135S-C3 has the highest resolution, followed by 160S-C3 and 80S-C3
(see Table 4.1). Relative density estimates: a sphere of radius = 3 pixels was centered on the designated spots (right
panel) and the average density computed. The density of C3 is almost the same as the density of the poliovirus
capsid in each case.

C3 Fab coordinates (17) were fitted into the cryo-EM density maps and used to deduce
changes that occur between 160S, 135S, and 80S particles. The C3 Fab was co-crystallized with
a peptide corresponding to part of the BC loop bound in the antigen-binding cleft. Assuming
that the Fab binds the free peptide in the same manner as when the BC loop is presented in the
context of viral particles, we included the peptide coordinates (corresponding to residues 93 to
103 of VP1) in our fitting to indicate the likely position of the epitope in the poliovirus-C3
complexes. Five regions of C3 Fab density around one fivefold vertex were used to fit
coordinates and the average (after symmetry operations to bring four of the five fittings to one
position) of all five fits is reported here.

160S-to-135S-to-80S Translational Movements
Comparison of fitted C3 coordinates in the 160S-C3 and 135S-C3 maps indicates that, during the
160S-to-135S transition, the BC-loop antigen changes radius at a similar ratio to undecorated
poliovirus (Table 4.2; Figs. 4.2B-D). For example, the distance between the fitted antigenic
peptide of C3 Fab and the center of the virus capsid increased 6.7 Å (4.4%) during the transition.
Comparing fitted coordinates of the five C3 densities surrounding a single fivefold vertex
showed that the distance between the fitted antigenic peptide of C3 Fab and the center of the
mesa increased 1.0 Å, 4.0%. These movements are consistent with previous observations of the
undecorated 160S and 135S particles, where comparisons of cryo-EM reconstructions showed a
4% expansion along the fivefold axis (1). Measurements of published models of the BC loops
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(2, 4) indicated that the distance from the center of the capsid increased 7.0 Å, 4.5%, and the
distance between BC loops and the center of mesa increased 0.9 Å, 4.0%. Therefore,
translational movements of the fitted antigenic peptide in 160S-C3 and 135S-C3 complexes are
consistent with positions of the BC loop in models of 160S (2) and 135S (4) particles.

Table 4.2 Distance measurements of the fitted antigenic peptide in 160S-C3 and 135S-C3
complexes (bound to antigen-binding domain of C3 Fab ¶) and BC loop (95-103 residues) in
160S1 and 135S2 particle models.

Entity
Antigenic
peptide
BC loop
¶

Model
Fit into
poliovirus-C3Fab
160S1, 135S2
coordinates

From
“entity” to
center of
mesa3
capsid
mesa3
capsid

Average Distance (Å) Average
160S-C3
135S-C3 Increase
(%)
or 160S
or 135S
24.8 ± 0.3 25.8 ± 0.2
4.0
152.8 ± 0.3 159.5 ± 0.2
4.4
22.6
23.5
4.0
155.3
162.3
4.5

Structure from reference (17), Protein Data Bank entry 1FPT.

1

Structure from reference (2), Protein Data Bank entry 1ASJ.

2

Structure from reference (4), Protein Data Bank entry 1XYR.

3

The center of the mesa lies along a fivefold symmetry axis.

In contrast to the large changes in the position of the BC loop in the 160S-to-135S
transition, the fit of the C3 Fab coordinates into the 80S-C3 3D map showed a similar position
and orientation of the Fab to that in the 135S-C3 map (Figs. 4.2C-D), inferring a similar position
of the C3 epitope in the two particle states. The lower resolution of the 80S-C3 map compared
to the 160S-C3 and 135S-C3 maps made the fit of the C3 Fab coordinates less reliable. Hence, a
detailed comparison was impractical. Assuming our fit of the antigen-binding domain of the C3
Fab is a reasonable approximation (Figs. 4.2C-D), the 135S-to-80S transition causes little change
in the position of the C3 antibody.
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Antibody binding changes BC loop position
One of the difficulties presented in building models of structures into cryo-EM reconstructions at
relatively low resolution is the need to minimize the number of parameters being fit. Except in
exceptional cases, this dictates the use of rigid-body approximations for protein subunits, even
with structures determined at sub-nanometer resolution. The prominent marker provided by the
density for the Fab, and the presence of the peptide corresponding to the BC loop in the C3 Fab
crystal structure, provides the opportunity to account for structural changes that take place in the
loop and more precisely position it in the models of the 160S-C3 and 135S-C3 complexes.
Using the Fab as a marker, our modeling places the BC loop in a different position with
respect to the remainder of VP1 than is observed in the crystal structure of the 160S particle (2)
or the model of the 135S particle (derived by rigid-body fitting of the capsid proteins to the cryoEM reconstruction) (4) (Fig. 4.3). To measure the deviation, we compared the positions of six
residues in the binding cleft of the fitted C3 Fab coordinates with their corresponding position in
the 160S (2) and 135S (4) models. That deviation is approximately 5 Å in both cases (Table 4.3).
Table 4.3 The deviation of residues in the BC loop in 160S1 and 135S2 models from the fitted
antigenic peptide in 160S-C3 and 135S-C3 complexes.*
Absolute distance (in Å) of each Cα atom in 160S1/135S2 residues
from the corresponding Cα in respective 160S-C3/135S-C3 fitting
97
98
99
100
101
102
Standard
Model Fitting SER THR THR ASN LYS ASP Average Deviation
160S1 160S-C3 2.2
2.8
4.0
6.3
8.9
5.7
5.0
2.5
2
135S 135S-C3 3.6
2.5
4.7
6.5
8.9
5.1
5.2
2.3
1

Structure from reference (2), Protein Data Bank entry 1ASJ.

2

Structure from reference (4), Protein Data Bank entry 1XYR.

*Only the distance between Ca coordinates was measured.
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Figure 4.3 Movements of BC loop of poliovirus VP1. Stereo views of BC and DE loops in 160S (magenta) and
135S (yellow), and antigenic peptide found in C3 Fab crystal structure after fitting of Fab coordinates into cryo-EM
maps of 160S-C3 (dark blue) and 135S-C3 (green) complexes. DE loops (loop between D and E β-strands of VP1)
are shown as a reference. (A) Stereo views of 5 sets of BC (farthest from axis), DE (closest to axis) loops, and fitted
antigenic peptides of C3 Fab (far from axis) viewed normal to a 5-fold axis (center of each panel). (B) One set of BC
loops, and antigenic peptides of C3 Fab viewed parallel to 5-fold symmetry axis (right side of each panel). DE
loops are on the left side of each panel. Although the average deviation of the peptides from the modeled BC loop
coordinates is nearly identical (see Table 4.2), the modeled 160S-C3 and 135S-C3 peptides are twisted 15° and
shifted 5.6 Å with respect to each other, reflecting the overall twist observed in the antigen-binding domain of the
Fab. The change in the BC loops modeled in the X-ray crystal (magenta; Protein Data Bank entry 1ASJ (2)) and
cryo-EM (yellow; Protein Data Bank entry 1XYR (4)) of 160S and 135S particles, respectively, is a twist of 4.6°
and shift of 2.6 Å. The corresponding change in the DE loop is a twist of 6° and shift of 4.1 Å. These changes in
loop positions were determined via the match function in UCSF Chimera (29), which determines rotation and
translation parameters to fit one object into another.
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Although the C3 Fab crystal coordinates included only a peptide of residues 93-103 (17),
the BC loop antigen should be bound in a similar position—at least in the antigen-binding cleft.
Therefore, the deviation indicates movement of the BC loop upon binding of C3 Fab. Our
modeling is based on the fitting of the antigen-binding domain into five symmetry-related
positions in the cryo-EM density, and therefore, placement of the antigen-binding cleft (which
included the peptide antigen). By placing the symmetry-related subunits in the same asymmetric
unit and averaging each fitted set of coordinates to give one average x, y, and z coordinate, we
determined an overall average x, y, and z coordinate and determined the fitting error (standard
deviation) to be 0.3 and 0.2 Å for the 160S-C3 and 135S-C3 fits, respectively. (We note that the
fitting algorithm uses internal density as well as the overall shape of the domain to determine
placement of the coordinates (30).) We compared bound residues 97-102 in the fitted Fab
structures (Cα coordinates only) to their corresponding residues in the BC loop of the 160S
crystal structure (2) or 135S pseudo-atomic model (4). We found a deviation per residue
between 2.2 and 8.9 Å (Table 4.3).
The Fab-bound C3 antigen—the BC loop—twists more extensively during the 160S-to135S transition than was deduced in the 135S pseudo-atomic model (4) (Fig. 4.3). Comparison
of the 160S-to-135S BC loop change in the X-ray crystal structure of 160S particle and the 135S
model showed a rotation of 4.6° and shift of 2.6 Å. Comparison of the same change in the fitted
coordinates of the 160S-C3 and 135S-C3 models showed a rotation of 15° and shift of 5.6 Å.
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4.4 Discussion
C3 antibody binds to the mesa tip
As expected from previous crystal and cryo-EM studies of 160S, 135S, and 80S particles (1, 2, 4,
19, 20), C3 Fab bound to the tip of the 5-fold mesa (Fig. 4.2). The binding affinities of C3 for
160S, 135S and 80S particles are similar (3), and we observed similar Fab:capsid density ratios
in the 160S-C3, 135S-C3, and 80S-C3 3D maps.

BC loop position is consistent with previous models
As viewed from the antigen-binding domain of the C3 antibody, the 160S-to-135S transition
shows an expansion in radius (Table 4.2; Figs. 4.2-3). The expansion of the capsid from 160S to
136S was 4.4 %, as measured by the position of the fitted antigenic peptide in 160S-C3 and
135S-C3 complexes. This measurement is consistent with the expansion of 4.0 % measured
previously (1). The 80S-C3 structure indicated little, if any, movement of the C3 Fab compared
to the C3 position in the 135S-C3 structure, which is also consistent with the previous models of
the 135S (4) and 80S (20) particles.

BC loop is flexible
Residues in the fitted BC-loop peptide deviated 2.2–8.9 Å (average, 5 ± 2 Å) from their positions
in the crystal structure of the 160S particle (2) and the model of the 135S particle (4) (Table 4.3;
Fig. 4.3). The low error of the core-weighted fitting (30) suggests that the 160S-C3 (error, 0.3 Å)
and 135S-C3 (error, 0.2 Å) reconstructions were sufficiently resolved (11 and 9 Å, respectively)
to allow such precise fitting and measurement of the BC-loop deviation.
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To make the binding interaction stronger and more specific, antibody and antigen may
change their conformations during binding (31). Binding of antibody to lysozyme induced
conformational changes in the antigen and those conformational changes were located at a
demonstrably flexible region (31). For the interaction of HIV-1 capsid protein p24 with
Fab13B5, conformational changes were observed in both antibody and antigen (32). For
example, Pro207 and Ala208, located in the turn between two helices, moved after Fab binding.
Pro207 moved 4 Å, which is comparable to the estimated movement of some residues in the BC
loop (Table 4.3). Therefore, because the deviation of the fitted, bound epitope against the BC
loop is identical (within experimental error) for the 160S-C3 and 135S-C3 structures (Table 4.3),
we postulate that binding of the C3 Fab causes the BC loop to change conformation. The
consistent deviation for the 160S-C3 and 135S-C3 structures suggests that the Fab interacts in a
similar manner with the two particle states and that the neighboring VP1 structure is also similar
for the 160S and 135S particles.
However, our fitting results suggest that the BC loop has a slightly different environment
in the 160S and 135S particles. Deviations of the fitted BC loop from the previously modeled
loops (2, 4) are slightly different in the 160S-C3 and 135S-C3 structures (Table 4.3, Fig. 4.3).
For example, during the 160S-to-135S transition, the BC loop in 160S-C3 and 135S-C3
complexes rotates 15° and shifts 5.6 Å, but the BC loop in the X-ray crystal structure of 160S
particle and the 135S model only rotates 4.6° and shifts 2.6 Å (Fig. 4.3).
The movement of the BC loop suggests that it is not strongly fixed at a certain
conformation, but can easily change its conformation. However, this flexibility is likely not
random, but is dictated by interactions with other proteins. In our structures, the conformational
change appears to be induced by the antibody-antigen binding interaction (31). Such inducible
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flexibility may be important in other interactions including cell entry. For example, poliovirus
receptor (CD155) is known to also interact with the mesa tip (33-36) and a flexible BC loop may
be important for that interaction.

Exit of the N-terminus of VP1
During the cell-entry process, receptor binding induces native poliovirus (160S) conversion to
the 135S cell-entry intermediate particle (3, 6). During this transition, the poliovirus
conformation changes with the externalization of membrane-binding entitites VP4 and the Nterminus of VP1. Competing models suggested that the N-terminus of VP1 exited through a
channel along the fivefold axis (37-39) or at the base of the canyon (1, 4). Our results support the
latter model.
Although BC loop moves as 160S particle transitions to the 135S particle form, the extent
of this movement is inconsistent with the “fivefold exit” model for VP1 and VP4 (37-39). The
BC loop of VP1 moves less than 1 Å from the center of the mesa (Table 4.2). If the N-terminus
of VP1 exits the capsid through the fivefold axis, the BC loop of VP1, and hence the position of
C3 Fab, must change significantly. The lack of significant movement supports a model in which
the N-terminus of VP1 does not exit through the fivefold axis.
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Chapter 5. Structure of the Fab-Labeled “Breathing” State of Native Poliovirus

5.1 Introduction
A protein “breathes” when it changes its conformation in reversible patterns. Such reversible
conformational changes may be necessary for some proteins to function properly.
The viral capsids of some non-enveloped viruses are dynamic structures with reversible
exposure of internal, unexposed amino-acid sequences under physiological conditions. This
dynamic behavior is often termed “breathing”. “Breathing” non-enveloped viruses include
picornaviruses, such as poliovirus (1, 2), human rhinovirus 14 (HRV14) (3, 4), HRV16 (4),
swine vesicular disease virus (5), and coxsackievirus (6); nodaviruses, such as Flock House virus
(FHV) (7); tetraviruses, such as Nudaurelia ω capensis and Helicoverpa armigera stunt virus
(8); bromoviruses, such as cowpea chlorotic mottle virus (9); tombusviruses, such as tomato
bushy stunt virus (10, 11); and sobemoviruses, such as southern bean mosaic virus (12).
Transient, reversible exposition of internal proteins may be an important step for the cell-entry
process, especially for conformational changes required to insert internal, hydrophobic,
membrane-binding peptides into the membrane (13-15).
“Breathing” in poliovirus was first discovered when antibodies to normally internal
amino-acid sequences, VP4 and the N-terminus of VP1, were found to bind to native particles (1,
2). The studies suggested that capsid “breathing” represented large dynamic changes in virion
structure at 37 ºC. To study this purported structure and mark the exposed N-terminus of VP1,
we utilized cryogenic electron microscopy (cryo-EM) and three-dimensional image
reconstruction to observe the structure of viruses incubated at 37 ºC with an Fab of a monoclonal
antibody to the designated region (2, 16).
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5.2 Materials and Methods
Poliovirus 1/Mahoney was grown and purified as described previously (17, 18). From a
preparation of monoclonal antibodies targeted to amino acids 39 to 55 of poliovirus type
1/Mahoney VP1 (2), Fab was prepared by the ImmunoPure® Fab preparation kit (Pierce,
Thermo Fisher Scientific, Rockford, Illinois, USA). Solutions of native poliovirus (sedimentation
coefficient 160S) and Fab were mixed at 37 ºC with an antibody-to-virus ratio of 95:1 and
incubated at 37 ºC for 2 hours.
Poliovirus-Fab mixture was suspended over holy carbon films. The grid was plungefrozen using an FEI Vitrobot (Hillsboro, Oregon, USA). The mixture was kept at 37 ºC until the
sample was plunge frozen. In the microscope, the grid was kept cold by a Gatan 626 cryoholder
(Pleasanton, California, USA), and micrographs were recorded on an FEI Tecnai F30
transmission electron microscope (Hillsboro, Oregon, USA) at magnification of 39,000× at 300
kV. The films were scanned with a Nikon 9000 ED film scanner (Tokyo, Japan).
Particle images were extracted with the X3DPREPROCESS program (19). The Bsoft
package was applied to determine and correct for contrast transfer function (CTF) effects (20)
via the algorithm by Conway and Steven (21). Focal settings ranged from 2.40 to 3.03 µm
underfocus. The PFT2 iterative model-based determination of orientations and origins (22, 23)
was used, and previous reconstructions of native poliovirus (sedimentation coefficient,160S)
(D.M. Belnap et al., unpublished) and the cell-entry intermediate (135S) particle (24) were the
starting models. A Fourier-Bessel algorithm was used to compute the 3D reconstruction (25).
Despite differences in the starting models, the capsid structure, the Fab density location and
volume, and the center slice of the two resulting maps were nearly identical. Because the capsid
structure and the RNA shape shown in the center slice of the map appeared more like the 135S
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particle than 160S particle, the map reconstructed by using the 135S particle as the starting
model was used for further image processing steps. In the micrograph, some 160S particles
appeared to have few or no Fab bound (data not shown). A previously determined, undecorated
poliovirus cryo-EM density map (particles at room temperature or lower before plunge freezing)
(D.M. Belnap et al., unpublished) and the initial 160S-37 °-Fab reconstruction served as the
starting models for multiple-model-based classification (26). Each particle image was compared
to a model projection from each state. Selected particles had a minimum difference of 0.04 in
the correlation-coefficient value between the correlation coefficients obtained from each form.
Finally, 137 particles were selected to reconstruct the structure of the 160S 37 °C “breathing”
state with Fab bound to a resolution of 25 Å.

5.3 Results and Discussion
Aggregation of particles was observed in cryo-EM micrograph. A cryo-EM micrograph of
160S (Fig. 5.1B) showed a relatively smooth outer capsid surface. On the other hand, the cryoEM micrograph of 160S complexed with Fab incubated at 37 °C for 2 hours (Fig. 5.1A) showed
that the capsid surface was not smooth and contained additional density, which indicates bound
Fab, externalized VP4 or the N-terminus of VP1, or both bound Fab and externalized
polypeptide. These particles were inclined to aggregate (Fig. 5.1A). Hydrophobic portions of
externalized peptides may cause the observed aggregation (14).

Exposed peptides in “breathing” structure are near the twofold axis. At low contour level,
the density map of the 160S-Fab complex at 37 ºC (Fig. 5.2A) showed that the Fab-binding site
is close to the 2-fold axis, which indicates that the N-terminus of VP1 exits from the internal
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capsid at the 2-fold axis in the poliovirus “breathing” state. The Fab density on the capsid is very
weak (Figs. 5.2A,E), which is due to the low occupancy of Fab on the capsid; the lack of a
defined Fab also indicates that the epitope is flexible (Lin et al., unpublished). The percentage of
the 60 subunits bound with Fab cannot be determined. The antibody used in this study showed a
stronger binding affinity with 135S and genome-released (80S) particles than with 160S particles
(2), which may occur because of the reversible transient externalization of N-terminus of VP1 or
the partial exposure of the peptide epitopes in the 160S “breathing” state. We note that exposed
polypeptides may contribute to the extra density we observed in the 160S-37 º-Fab complex
(Figs. 5.2A,E). Fab density likely makes up the largest portion despite the lack of complete
correspondence with the shape of an Fab.
At 37 °C, 160S likely has a dynamic structure because of the reversible externalization of
the internal peptides. Therefore, externalized polypeptides in the “breathing” state probably have
multiple conformations. The 160S-37°-Fab complex reported here may be an average of multiple
“breathing” states or only one of multiple “breathing” states. The relatively low resolution of the
map suggests that multiple conformations were averaged.

Figure 5.1 Electron micrographs of frozen-hydrated poliovirus. (A) A complex of 160S and Fab to the 39-55
residues of VP1 incubated at 37 ºC for 2 hours. (B) 160S particles. Bar = 30 nm.
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Figure 5.2 Structure of 160S-37º-Fab complex compared to 160S and 135S particles. Surface representations of
the three-dimensional structures of 160S-Fab complex at 37 ºC (A-B). 160S and Fab to the 39-55 residues of VP1
were incubated at 37 °C for 2 hours. 160S-37º-Fab complex reconstructions at resolution 25 Å at contour levels of
0σ (A) and 1.3σ (B). 160S (D.M. Belnap et al., unpublished) (C) and 135S (27) (D) maps are shown at contour
level 0σ. Central sections of the poliovirus 160S-37º-Fab complex (E), 160S (F), and 135S (G) reconstructions. The
sections are perpendicular to the twofold symmetry axes. Fab densities are on the twofold axes (white arrows). Some
symmetry axes are labeled. The markers perpendicular to each symmetry axis, 5-fold (pentagon), 3-fold (triangle),
and 2-fold (oval), show the radius of the 160S structure. Scale bar for panels E, F and G = 100 Å.

Comparison of reversible “breathing” and irreversible 160S-to-135S changes. During cell
entry, poliovirus receptor (CD155) interacts with a 160S particle and induces the formation of
the intermediate 135S particle (18, 28). This transition includes the irreversible externalization of
VP4 and the N-terminus of VP1 from the internal side of the capsid (18, 28). Previous authors
have asked whether the reversible exposition of these same polypeptides during “breathing” is
similar to the irreversible changes that occur in the 160S-to-135S transition (1, 15).
The structure of the 160S-37°-Fab complex (Fig. 5.2B) differs from the 160S structure
(Fig. 5.2C). By comparing central density slices of 160S-37°-Fab, 160S, and 135S maps (Fig.
5.2E-G), we observed that the 160S-37°-Fab capsid is ~7% larger than 160S and ~4% larger than
135S at the fivefold axis, ~1% larger than 160S and ~3% smaller than 135S at the twofold axis,
but nearly same as 160S and 135S at the threefold axis. These comparisons are similar to the
difference between the 135S and 160S particle states observed previously (24). The shape of the
RNA in the 160S-37°-Fab complex appears more similar to that in the 135S particle than the
RNA in the 160S structure (Fig. 5.2E-G). Therefore, the 160S “breathing” structure resembles
the 135S state in at least two significant features.
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VP4 and the N-terminus of VP1 were observed to externalize from the internal poliovirus
capsid in the 160S “breathing” process and in 160S-to-135S transition (29, 30). The expansion of
the capsid may facilitate externalization of the internal peptides (15). Functionally, the
externalization of internal amino-acid sequences in 160S-to-135S transition is similar to
externalization of the same sequences in the “breathing” process of poliovirus (1, 15), which may
be the reason that the 160S-37º-Fab map is similar to the 135S map (Fig. 5.2). Bound Fab may
stabilize externalization of the internal peptides (VP4 and the N-terminus of VP1) and keep these
particles in the “breathing” state.
However, the conformational change from the 160S “closed” state to 160S “breathing”
state or to 135S differs. At 37 °C, the internal protein exits the capsid reversibly in 160S
“breathing” state. In the 160S-to-135S transition, the irreversible conformational change leads
the permanent externalization. The 160S X-ray crystal structure (31) showed that residues 39-55
spans the inside of the capsid from the propeller edge to near the 2-fold axis depression. The
160S-37 º-Fab map (Fig. 5.2A) showed the N-terminus of VP1 exits from the internal capsid at
the 2-fold axis in the poliovirus “breathing” state. In the 135S cryo-EM model (27), only
residues 42-52 were shown, which were located at the canyon between the mesa and propeller tip.
The V8-cleaved 135S (27) or 135S-Fab complex (Fab binds to the 24-40 residues of VP1) (Lin
et al., submitted) showed that the N-terminus of VP1 locates at the propeller tip. The different
location of the N-terminus of VP1 in the 160S “breathing” state and 135S particle indicates that
these two externalization of internal sequence processes are distinct. Some antiviral drugs can
inhibit the formation of 135S particles but cannot inhibit the formation of the “breathing” state of
160S particles, which indicated that the poliovirus “breathing” differs from the formation of
135S (1). Nevertheless, as previously noted (15), “breathing” indicates a dynamic capsid
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structure that is primed to undergo irreversible changes. Perhaps activation by the poliovirusreceptor interaction or heating (18, 32) is, in forming the 135S particle, able to direct the Nterminus in a different direction from the reversible exposure observed at 37 °C.
The 160S-37º-Fab complex and 135S particle (27, 30) show that externalization of the
internal sequences is linked to or concurrent with capsid expansion. The different location of Nterminus of VP1 on 160S capsid in “breathing” state and 135S capsid indicates that
externalization has two pathways and may have different roles in “breathing” and cell entry.
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Chapter 6. Conclusion and Future Work

6.1 Conclusion
In Chapter 1 and 2, I explained the biological properties of poliovirus, the current understanding
of poliovirus cell entry, the methodology of cryo-EM biomolecular structure analysis and the use
of antibodies to detect antigen location. This is the basis of my research. My research target is
poliovirus, the main technique I used to obtain the 3D structure of poliovirus-Fab complexes is
cryogenic electron microscopy (cryo-EM) and three-dimensional image reconstruction,
specifically single-particle analysis. I used three different antibodies to track different portions of
the N-terminus of VP1 in poliovirus particles to understand more about poliovirus cell entry.
In Chapter 3, The Fab fragment of a monospecific “P1” antibody, which was raised
against a peptide corresponding to N-terminal residues 24-40 of VP1, was utilized to track the
location of the N-terminus of VP1 in the 135S and 80S states of poliovirus particles. On 135S,
P1 Fabs bind to a prominent feature on the external surface known as the “propeller tip”. In
contrast, our initial 80S-P1 reconstruction showed P1 Fabs also binding to a second site, ~60 Å
distant, at the icosahedral twofold axes. Further analysis showed that the overall population of
80S-P1 particles consisted of three kinds of capsids: those with P1 Fabs bound only at the
propeller tips; only at the twofold axes; or simultaneously at both positions. Our results indicate
that, in 80S particles, a significant fraction of VP1 can deviate from icosahedral symmetry.
Hence, this portion of VP1 does not change conformation synchronously when switching from
the 135S state. These conclusions are compatible with previous observations of multiple
conformations of the 80S state and suggest that movement of the N-terminus of VP1 has a role in
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uncoating. Similar deviations from icosahedral symmetry may be biologically significant during
other viral transitions.
In Chapter 4, we tracked the location of the external BC loop of VP1 (residues 95-105) in
160S, 135S, and 80S particles by labeling them with the C3 monoclonal antibody, determining
their three-dimensional structures by cryogenic electron microscopy (cryo-EM), and fitting
atomic-resolution coordinates into the resulting density maps. The C3 epitope, located on the tip
of a prominent peak known as the “mesa”, shifts outwards in radius by 4.5% and twists through
15° in the 160S-to-135S transition, but appears unchanged in the 135S-to-80S transition. In
addition, binding of C3 to either 160S or 135S particles causes residues of the BC loop to move
an estimated 5 (±2) Å, indicating flexibility. The flexibility of this loop may play a role in cellentry interactions and give us structural information for antiviral drug design. A potential
antiviral drug, which can bind and stabilize the BC loop, may prevent receptor binding and
inhibit cell entry.
In Chapter 5, An Fab fragment of a monoclonal antibody, binding to the residues 39-55
of VP1, was utilized to track the location of the N-terminus of VP1 in the native (160S) particle
in this “breathing” state. At 37 °C, the structure of poliovirus is dynamic, and internal
polypeptides VP4 and the N-terminus of VP1 externalize reversibly, which is “capsid breathing”.
Fab and virus were mixed at 37 ºC and imaged via cryogenic electron microscopy. The resulting
reconstruction showed the capsid expands similarly to the irreversibly altered cell-entry
intermediate (135S) particle, but the N-terminus of VP1 is located near the twofold axes, instead
of the propeller tip as in 135S particles.
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6.2 Future Work
6.2.1 Further studies on poliovirus
160S “breathing” structure at high resolution
The 160S "breathing" structure shown in Chapter 5 is at 25-Å resolution. A higher resolution
(represented by a lower numerical value) structure would give more information. To obtain a
high-resolution “breathing” structure, Fabs which bind to the N-terminus of poliovirus VP1 with
a higher affinity than those used in Chapter 5 could prove beneficial. At 37 ºC, the 160S particles
will have a higher occupancy of Fab, due to its greater affinity, this might allow a greater
population of 160S particles to stay at a certain “breathing” state. These more tightly bound
160S-Fab particles will produce a higher resolution 3D reconstruction because more of them will
be in a uniform state.

More comparison data between 160S particles in “breathing” state and 135S particles
The position of residues 39-55 of the N-terminus of VP1 in 160S “breathing” particles is shown
by the 160S-37º-Fab map (see Chapter 5) while the position of the N-terminus of VP1 in 135S is
shown by V8-cleaved 135S maps (showing the location of the first 31 residues of VP1 (1)) and
135S-P1 maps (showing the location of residues 24-40 of VP1, see Chapter 3). A 135S-Fab (Fab
binding to residues 39-55 of the N-terminus of poliovirus VP1) structure would allow us to
directly compare the antigen position in 160S “breathing” particles and 135S particles. I did
some preliminary work for the reconstruction of this 135S-Fab complex, but more work needs to
be done.
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Identification of the exposed peptides in 160S “breathing” particles and 135S particles by
mass spectrometry
The high sensitivity and accuracy of matrix-assisted laser desorption/ionization mass
spectrometry (MALDI-MS) make it a useful method for identifying the proteolysis products of
viruses. For example, the results of limited proteolysis/MALDI-MS on HRV14 and FHV showed
that internal peptides are part of the solvent-accessible domain and are transiently present on the
capsid surface (2, 3). Limited proteolysis/MALDI-MS is another method that can be used on
160S “breathing” particles and 135S particles to identify the exposed residues from the Nterminus of VP1. If the MALDI-MS experiment was run on both types of particles, the exposed
residues could be compared. This would further clarify the biological similarity or difference
between the reversible externalization of VP1 in 160S “capsid breathing” and the irreversible
externalization of VP1 during the 160S-to-135S transition.

6.2.2 Application of the Fab-labeling technique to other systems
Poliovirus is the only nonenveloped virus in which I studied the externalization of the internal
capsid proteins of the noneveloped virus. Cell entry of nonenveloped viruses is not well
understood, but often involves externalization of internally located peptides. For example, this
occurs in human rhinovirus 2 (HRV2) (4), HRV16 (5) and FHV (3). Future work could apply
similar methods (to track the externalization via virus-antibody interactions with cryo-EM) as I
showed in Chapters 2-5 on the HRV2, HRV16 and FHV systems to observe where the internal
capsid proteins exit from the capsid.
HRVs belong to the picornavirus family and are the most frequent cause of the common
cold. HRVs are classified into two groups depending on their cellular receptors. The intercellular
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adhesion molecule 1 (ICAM-1 or CD54) is the receptor for the major group, and members of the
low-density-lipoprotein receptor (LDL-R) family act as receptors for the minor group. The
binding site of ICAM-1 on the major group HRV, such as HRV16, is located in the canyon (6)
(7). This is the same area where poliovirus receptor binds (Fig. 6.1) (8). Receptor binds into the
canyon, which destabilizes the virus and initiates the uncoating process. The binding site of
very-low-density-lipoprotein receptor (VLDL-R) on the minor-group HRV, such as HRV2, is on
the mesa (Fig. 6.1) (9), not in the canyon like that of major-group HRVs. Receptors bind outside
the canyon and do not cause viral instability and the uncoating process of HRV2 is triggered at
the plasma membrane by acidification (10). The use of antibodies could show whether the Nterminus of VP1 is externalized at the same site when the virus receptor binds to a same or
different position on the virus capsid. In other words, we should learn whether the
externalization of VP1 occurs similarly among viruses that have the same or different types of
receptors (i.e. same or different receptor-binding sites).

Figure 6.1. Cryo-EM image reconstructions of three complexes between picornaviruses and soluble fragments of
their receptors adapted from (6, 8, 9). Left panel: reconstruction of poliovirus (red) complexed with CD155 (blue).
Middle panel: reconstruction of the complex between HRV16 and ICAM-1. Right panel: reconstruction of the
complex between HRV2 with VLDL-R. Fivefold (pentagon), threefold (triangle) and twofold symmetry axes are
labeled. Bar =100 Å.
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FHV is one of the notable members of the nodaviruses family. Nodaviruses comprise a
family of small, icosahedral, non-enveloped, RNA viruses that naturally infect insects and fish
(11). Similar to picornaviruses, nodaviruses enter cells via receptor-binding-induced endocytosis;
the next step is virus uncoating by passing RNA across the endosomal membrane (12). Even
though FHV belongs to the nodavirus family instead of the picornavirus family, its structural
properties, such as the icosahedral, non-enveloped capsid, ssRNA genome, and the
externalization of the internal peptides, is similar to poliovirus (3). The study of the
externalization of internal peptides will show us if the poliovirus cell-entry model (e.g. the
exposure of membrane-binding polypeptides) is suitable for other virus families. If so, this may
suggest a general mechanism for non-enveloped virus cell-entry. It may also have applicability in
other similar interactions of protein and membrane (non-viral interactions).
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